Agios Pharmaceuticals Inc. (AGIO) NASDAQ
$31.66 (0.15) (-0.47%)
Market Cap: $1.79B
As of 04/24/24 02:48 PM EDT. Market open.
Agios Pharmaceuticals Inc. (AGIO)
NASDAQ
$31.66
(0.15) (-0.47%)
Market Cap: $1.79B
As of 04/24/24 02:48 PM EDT. Market open.
Add to Portfolio
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacqualyn Fouse
Full Time Employees
883
CEO Compensation (Base)
$625,000
CEO Compensation (Total)
$8.20M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Jacqualyn Fouse
Full Time Employees
883
CEO Compensation (Base)
$625,000
CEO Compensation (Total)
$8.20M
URL
Address
88 Sidney St, Massachusetts, Cambridge, 02139-4137.
PRICE CHART FOR AGIOS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$32.09
Previous Close
$31.81
Days Range
$30.40 - $33.01
52 week range
$19.80 - $35.50
Volume
198,161
Avg. Volume (30 days)
656,334
Market Cap
$1.79B
Dividend Yield
-
P/E
1.12
Shares Outstanding
56,194,847
Open
$32.09
Previous Close
$31.81
Days Range
$30.40 - $33.01
52 week range
$19.80 - $35.50
Volume
198,161
Avg. Volume (30 days)
656,334
Market Cap
$1.79B
Dividend Yield
-
P/E
1.12
Shares Outstanding
56,194,847
FINANCIAL STATEMENTS FOR AGIOS PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR AGIOS PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
FOUSE JACQUALYN A | Director | Apr 10, 2024 | Sale | $27.55 | 7,791 | 214,642 | 137,396 | Apr 10, 2024, 04:03 PM |
Foster-Cheek Kaye I | Director | Mar 07, 2024 | Sale | $31.62 | 1,285 | 40,632 | 5,524 | Mar 11, 2024, 04:09 PM |
Foster-Cheek Kaye I | Director | Mar 06, 2024 | Sale | $31.99 | 4,415 | 141,236 | 6,809 | Mar 07, 2024, 06:49 PM |
Foster-Cheek Kaye I | Director | Mar 05, 2024 | Sale | $32.21 | 300 | 9,663 | 11,224 | Mar 07, 2024, 06:49 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Mar 05, 2024 | Sale | $31.75 | 1,913 | 60,738 | 2,886 | Mar 07, 2024, 06:47 PM |
Burns James William | Chief Legal Officer | Mar 05, 2024 | Sale | $32.57 | 2,642 | 86,050 | 37,169 | Mar 05, 2024, 04:08 PM |
Schenkein David P | Director | Feb 27, 2024 | Option Exercise | $31.64 | 69,329 | 2,193,570 | 180,325 | Feb 29, 2024, 04:05 PM |
Schenkein David P | Director | Feb 27, 2024 | Sale | $34.67 | 69,329 | 2,403,592 | 122,854 | Feb 29, 2024, 04:05 PM |
Schenkein David P | Director | Feb 26, 2024 | Option Exercise | $31.64 | 20,411 | 645,804 | 143,265 | Feb 27, 2024, 04:04 PM |
Schenkein David P | Director | Feb 23, 2024 | Option Exercise | $31.64 | 47,731 | 1,510,209 | 170,585 | Feb 27, 2024, 04:04 PM |
Schenkein David P | Director | Feb 26, 2024 | Sale | $33.19 | 20,411 | 677,441 | 122,854 | Feb 27, 2024, 04:04 PM |
Schenkein David P | Director | Feb 23, 2024 | Sale | $33.05 | 47,731 | 1,577,510 | 122,854 | Feb 27, 2024, 04:04 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 20, 2024 | Sale | $26.63 | 504 | 13,422 | 2,741 | Feb 22, 2024, 05:43 PM |
Gheuens Sarah | Chief Medical Officer | Feb 14, 2024 | Sale | $25.14 | 642 | 16,140 | 33,431 | Feb 14, 2024, 05:53 PM |
Burns James William | Chief Legal Officer | Feb 14, 2024 | Sale | $25.14 | 545 | 13,701 | 31,666 | Feb 14, 2024, 05:51 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2024 | Sale | $25.14 | 273 | 6,863 | 3,245 | Feb 14, 2024, 05:50 PM |
Burns James William | Chief Legal Officer | Jan 24, 2024 | Sale | $21.64 | 1,708 | 36,961 | 30,378 | Jan 24, 2024, 04:25 PM |
Gheuens Sarah | Chief Medical Officer | Jan 24, 2024 | Sale | $21.64 | 1,708 | 36,961 | 31,911 | Jan 24, 2024, 04:24 PM |
Jones Cecilia | Chief Financial Officer | Jan 24, 2024 | Sale | $21.64 | 1,886 | 40,813 | 13,069 | Jan 24, 2024, 04:23 PM |
FOUSE JACQUALYN A | Director | Jan 24, 2024 | Sale | $21.64 | 10,722 | 232,024 | 129,253 | Jan 24, 2024, 04:22 PM |
Goff Brian | Chief Executive Officer | Jan 24, 2024 | Sale | $21.64 | 7,635 | 165,221 | 49,436 | Jan 24, 2024, 04:20 PM |
Milanova Tsveta | Chief Commercial Officer | Jan 24, 2024 | Sale | $21.64 | 1,618 | 35,014 | 13,234 | Jan 24, 2024, 04:19 PM |
Goff Brian | Chief Executive Officer | Jan 09, 2024 | Sale | $22.99 | 12,066 | 277,397 | 40,053 | Jan 09, 2024, 04:28 PM |
FOUSE JACQUALYN A | Director | Jan 09, 2024 | Sale | $22.99 | 8,391 | 192,909 | 116,075 | Jan 09, 2024, 04:26 PM |
Burns James William | Chief Legal Officer | Jan 09, 2024 | Sale | $22.99 | 1,163 | 26,737 | 26,336 | Jan 09, 2024, 04:25 PM |
Gheuens Sarah | Chief Medical Officer | Jan 09, 2024 | Sale | $22.99 | 1,789 | 41,129 | 27,869 | Jan 09, 2024, 04:22 PM |
Milanova Tsveta | Chief Commercial Officer | Jan 05, 2024 | Sale | $22.32 | 2,902 | 64,773 | 9,404 | Jan 05, 2024, 04:10 PM |
Jones Cecilia | Chief Financial Officer | Sep 28, 2023 | Sale | $24.79 | 2,179 | 54,017 | 9,575 | Sep 28, 2023, 04:02 PM |
Burns James William | Chief Legal Officer | Aug 17, 2023 | Sale | $26.28 | 6,395 | 168,061 | 23,890 | Aug 21, 2023, 04:03 PM |
Foster-Cheek Kaye I | Director | Aug 09, 2023 | Option Exercise | $18.09 | 25,000 | 452,250 | 36,524 | Aug 11, 2023, 04:04 PM |
Foster-Cheek Kaye I | Director | Aug 09, 2023 | Sale | $25.96 | 25,000 | 648,887 | 11,524 | Aug 11, 2023, 04:04 PM |
Goff Brian | Chief Executive Officer | Aug 08, 2023 | Sale | $25.48 | 10,178 | 259,335 | 26,592 | Aug 10, 2023, 04:07 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Aug 07, 2023 | Sale | $25.39 | 2,918 | 74,096 | 2,741 | Aug 09, 2023, 04:04 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Aug 01, 2023 | Sale | $26.26 | 1,232 | 32,352 | 5,659 | Aug 02, 2023, 04:02 PM |
Burns James William | Chief Legal Officer | Jun 30, 2023 | Sale | $28.36 | 1,707 | 48,411 | 30,285 | Jun 30, 2023, 04:09 PM |
FOUSE JACQUALYN A | Director | Jun 30, 2023 | Sale | $28.36 | 10,718 | 303,962 | 106,966 | Jun 30, 2023, 04:07 PM |
Gheuens Sarah | Chief Medical Officer | Jun 30, 2023 | Sale | $28.36 | 1,707 | 48,411 | 24,159 | Jun 30, 2023, 04:06 PM |
Goff Brian | Chief Executive Officer | Jun 30, 2023 | Sale | $28.36 | 11,449 | 324,694 | 14,079 | Jun 30, 2023, 04:05 PM |
Jones Cecilia | Chief Financial Officer | Jun 30, 2023 | Sale | $28.36 | 1,597 | 45,291 | 3,783 | Jun 30, 2023, 04:03 PM |
Milanova Tsveta | Chief Commercial Officer | Jun 30, 2023 | Sale | $28.36 | 1,618 | 45,886 | 3,831 | Jun 30, 2023, 04:02 PM |
FOUSE JACQUALYN A | Director | Apr 12, 2023 | Option Exercise | $21.35 | 4,731 | 101,007 | 93,784 | Apr 12, 2023, 04:17 PM |
Schenkein David P | Director | Apr 03, 2023 | Option Exercise | $9.05 | 16,363 | 148,085 | 134,242 | Apr 05, 2023, 04:03 PM |
Schenkein David P | Director | Apr 03, 2023 | Sale | $22.85 | 16,363 | 373,895 | 117,879 | Apr 05, 2023, 04:03 PM |
Schenkein David P | Director | Mar 27, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Mar 29, 2023, 09:30 PM |
Schenkein David P | Director | Mar 27, 2023 | Sale | $22.15 | 20,000 | 443,000 | 117,879 | Mar 29, 2023, 09:30 PM |
Schenkein David P | Director | Mar 13, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Mar 15, 2023, 05:11 PM |
Schenkein David P | Director | Mar 13, 2023 | Sale | $22.49 | 20,000 | 449,817 | 119,546 | Mar 15, 2023, 05:11 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Mar 03, 2023 | Sale | $24.29 | 504 | 12,242 | 2,741 | Mar 07, 2023, 04:02 PM |
Gheuens Sarah | Chief Medical Officer | Mar 03, 2023 | Option Exercise | $25.02 | 1,134 | 28,373 | 20,116 | Mar 03, 2023, 04:05 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2023 | Option Exercise | $28.91 | 127 | 3,672 | 3,405 | Feb 16, 2023, 04:04 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2023 | Sale | $28.59 | 504 | 14,409 | 2,901 | Feb 16, 2023, 04:04 PM |
Burns James William | Chief Legal Officer | Feb 16, 2023 | Option Exercise | $28.91 | 609 | 17,606 | 23,538 | Feb 16, 2023, 04:04 PM |
FOUSE JACQUALYN A | Director | Feb 16, 2023 | Option Exercise | $28.91 | 3,648 | 105,464 | 82,582 | Feb 16, 2023, 04:03 PM |
Schenkein David P | Director | Feb 13, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Feb 15, 2023, 04:03 PM |
Schenkein David P | Director | Feb 13, 2023 | Sale | $28.62 | 20,000 | 572,400 | 117,879 | Feb 15, 2023, 04:03 PM |
Burns James William | Chief Legal Officer | Feb 14, 2023 | Option Exercise | $28.44 | 643 | 18,287 | 22,409 | Feb 14, 2023, 04:07 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2023 | Option Exercise | $28.44 | 273 | 7,764 | 3,172 | Feb 14, 2023, 04:06 PM |
Schenkein David P | Director | Jan 30, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Feb 01, 2023, 04:04 PM |
Schenkein David P | Director | Jan 30, 2023 | Sale | $29.33 | 20,000 | 586,578 | 121,179 | Feb 01, 2023, 04:04 PM |
Schenkein David P | Director | Jan 17, 2023 | Option Exercise | $9.05 | 20,000 | 181,000 | 137,879 | Jan 19, 2023, 04:03 PM |
Schenkein David P | Director | Jan 17, 2023 | Sale | $28.85 | 20,000 | 577,093 | 118,913 | Jan 19, 2023, 04:03 PM |
Burns James William | Chief Legal Officer | Dec 28, 2022 | Option Exercise | $28.48 | 2,597 | 73,963 | 21,218 | Dec 28, 2022, 04:05 PM |
Gheuens Sarah | Chief Medical Officer | Dec 28, 2022 | Option Exercise | $28.48 | 2,783 | 79,260 | 15,605 | Dec 28, 2022, 04:05 PM |
Gheuens Sarah | Chief Medical Officer | Dec 06, 2022 | Option Exercise | $28.83 | 248 | 7,150 | 9,013 | Dec 06, 2022, 04:14 PM |
Poddar Richa | Chief Commercial Officer | Oct 17, 2022 | Option Exercise | $27.48 | 1,485 | 40,808 | 8,508 | Oct 18, 2022, 04:17 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 25, 2022 | Sale | $30.00 | 108 | 3,240 | 2,549 | Mar 01, 2022, 04:54 PM |
Gheuens Sarah | Chief Medical Officer | Feb 22, 2022 | Option Exercise | $29.08 | 955 | 27,771 | 7,768 | Feb 23, 2022, 04:12 PM |
Poddar Richa | Chief Commercial Officer | Feb 22, 2022 | Option Exercise | $29.08 | 742 | 21,577 | 4,441 | Feb 23, 2022, 04:11 PM |
Car Bruce | Chief Scientific Officer | Feb 22, 2022 | Option Exercise | $29.08 | 2,041 | 59,352 | 16,752 | Feb 23, 2022, 04:11 PM |
Biller Jonathan | Chief Financial Officer | Feb 22, 2022 | Option Exercise | $29.08 | 2,688 | 78,167 | 22,953 | Feb 23, 2022, 04:10 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Feb 22, 2022 | Option Exercise | $29.08 | 3,674 | 106,840 | 74,897 | Feb 23, 2022, 04:10 PM |
Burns James William | Chief Legal Officer | Feb 22, 2022 | Option Exercise | $29.08 | 215 | 6,252 | 14,793 | Feb 23, 2022, 04:10 PM |
Schenkein David P | Director | Feb 22, 2022 | Option Exercise | $29.08 | 758 | 22,043 | 116,294 | Feb 23, 2022, 04:09 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 22, 2022 | Option Exercise | $29.08 | 59 | 1,716 | 2,657 | Feb 23, 2022, 04:09 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 16, 2022 | Sale | $30.81 | 233 | 7,179 | 2,549 | Feb 18, 2022, 04:56 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Feb 14, 2022 | Option Exercise | $30.50 | 3,505 | 106,903 | 66,192 | Feb 16, 2022, 05:01 PM |
Burns James William | Chief Legal Officer | Feb 14, 2022 | Option Exercise | $30.50 | 2,155 | 65,728 | 14,284 | Feb 16, 2022, 05:01 PM |
Poddar Richa | Chief Commercial Officer | Feb 14, 2022 | Option Exercise | $30.50 | 590 | 17,995 | 2,641 | Feb 16, 2022, 05:00 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2022 | Option Exercise | $30.50 | 127 | 3,874 | 3,286 | Feb 16, 2022, 05:00 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 14, 2022 | Sale | $31.25 | 504 | 15,750 | 2,782 | Feb 16, 2022, 05:00 PM |
Gheuens Sarah | Chief Medical Officer | Feb 10, 2022 | Option Exercise | $31.42 | 758 | 23,820 | 5,452 | Feb 14, 2022, 04:09 PM |
Washburn Theodore James Jr. | Principal Accounting Officer | Feb 10, 2022 | Option Exercise | $31.42 | 273 | 8,579 | 3,019 | Feb 14, 2022, 04:08 PM |
Biller Jonathan | Chief Financial Officer | Feb 10, 2022 | Option Exercise | $31.42 | 1,349 | 42,392 | 17,118 | Feb 14, 2022, 04:08 PM |
Burns James William | Chief Legal Officer | Feb 10, 2022 | Option Exercise | $31.42 | 643 | 20,206 | 9,451 | Feb 14, 2022, 04:06 PM |
Poddar Richa | Chief Commercial Officer | Feb 10, 2022 | Option Exercise | $31.42 | 725 | 22,783 | 1,493 | Feb 14, 2022, 04:06 PM |
Car Bruce | Chief Scientific Officer | Jan 06, 2022 | Option Exercise | $32.58 | 1,205 | 39,259 | 9,325 | Jan 10, 2022, 04:06 PM |
Gheuens Sarah | Chief Medical Officer | Dec 02, 2021 | Option Exercise | $35.00 | 248 | 8,680 | 4,048 | Dec 07, 2021, 04:18 PM |
Biller Jonathan | Chief Financial Officer | Dec 03, 2021 | Option Exercise | $35.88 | 1,823 | 65,406 | 14,800 | Dec 07, 2021, 04:18 PM |
Alenson Carman | Principal Accounting Officer | Jun 21, 2021 | Option Exercise | $51.51 | 1,777 | 91,533 | 1,777 | Jun 23, 2021, 05:28 PM |
Alenson Carman | Principal Accounting Officer | Jun 21, 2021 | Sale | $61.61 | 1,777 | 109,481 | 0 | Jun 23, 2021, 05:28 PM |
Bowden Christopher | Chief Medical Officer | Jun 18, 2021 | Option Exercise | $49.99 | 48,493 | 2,423,991 | 63,980 | Jun 22, 2021, 04:44 PM |
Bowden Christopher | Chief Medical Officer | Jun 18, 2021 | Sale | $60.11 | 48,493 | 2,914,851 | 15,487 | Jun 22, 2021, 04:44 PM |
Miles Darrin | Chief Commercial Officer | May 14, 2021 | Sale | $55.41 | 3,462 | 191,829 | 7,209 | May 18, 2021, 04:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 20, 2021 | Option Exercise | $35.76 | 14,401 | 515,024 | 29,888 | Apr 21, 2021, 05:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 19, 2021 | Option Exercise | $35.16 | 3,210 | 112,864 | 18,697 | Apr 21, 2021, 05:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 20, 2021 | Sale | $55.11 | 14,401 | 793,581 | 15,487 | Apr 21, 2021, 05:11 PM |
Bowden Christopher | Chief Medical Officer | Apr 19, 2021 | Sale | $55.16 | 3,210 | 177,055 | 15,487 | Apr 21, 2021, 05:11 PM |
Miles Darrin | Chief Commercial Officer | Mar 05, 2021 | Sale | $48.58 | 500 | 24,290 | 10,671 | Mar 16, 2021, 04:14 PM |
Miles Darrin | Chief Commercial Officer | Mar 01, 2021 | Sale | $47.99 | 2,200 | 105,578 | 11,171 | Mar 16, 2021, 04:14 PM |
Biller Jonathan | Chief Financial Officer | Dec 03, 2020 | Option Exercise | $45.87 | 1,707 | 78,300 | 10,040 | Dec 07, 2020, 06:21 PM |
Alenson Carman | Principal Accounting Officer | Sep 02, 2020 | Sale | $39.93 | 250 | 9,983 | 184 | Sep 04, 2020, 04:24 PM |
Bowden Christopher | Chief Medical Officer | May 20, 2020 | Option Exercise | $35.16 | 3,583 | 125,978 | 11,889 | May 21, 2020, 05:05 PM |
Bowden Christopher | Chief Medical Officer | May 20, 2020 | Sale | $50.01 | 3,583 | 179,200 | 8,306 | May 21, 2020, 05:05 PM |
Hirsch Andrew | Chief Financial Officer | Apr 22, 2020 | Option Exercise | $45.91 | 1,927 | 88,469 | 24,272 | Apr 24, 2020, 04:06 PM |
Biller Jonathan | Chief Legal Officer | Apr 14, 2020 | Option Exercise | $40.64 | 2,529 | 102,779 | 5,994 | Apr 15, 2020, 04:27 PM |
Hirsch Andrew | Chief Financial Officer | Apr 14, 2020 | Option Exercise | $40.64 | 1,599 | 64,983 | 20,306 | Apr 15, 2020, 04:26 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Apr 14, 2020 | Option Exercise | $40.64 | 3,673 | 149,271 | 50,428 | Apr 15, 2020, 04:26 PM |
Car Bruce | Chief Scientific Officer | Apr 14, 2020 | Option Exercise | $40.64 | 2,027 | 82,377 | 4,847 | Apr 15, 2020, 04:25 PM |
Bowden Christopher | Chief Medical Officer | Apr 14, 2020 | Option Exercise | $40.64 | 2,368 | 96,236 | 8,230 | Apr 15, 2020, 04:25 PM |
Alenson Carman | Principal Accounting Officer | Mar 02, 2020 | Sale | $47.30 | 345 | 16,318 | 184 | Mar 04, 2020, 05:08 PM |
Alenson Carman | Principal Accounting Officer | Feb 26, 2020 | Sale | $47.12 | 472 | 22,241 | 184 | Feb 28, 2020, 04:17 PM |
Hirsch Andrew | Chief Financial Officer | Feb 24, 2020 | Option Exercise | $48.66 | 1,056 | 51,385 | 16,518 | Feb 25, 2020, 04:27 PM |
Bowden Christopher | Chief Medical Officer | Feb 24, 2020 | Option Exercise | $48.66 | 1,596 | 77,661 | 5,318 | Feb 25, 2020, 04:26 PM |
Schenkein David P | Director | Feb 24, 2020 | Option Exercise | $48.66 | 880 | 42,821 | 105,053 | Feb 25, 2020, 04:25 PM |
Alenson Carman | Principal Accounting Officer | Feb 24, 2020 | Option Exercise | $48.66 | 219 | 10,657 | 656 | Feb 25, 2020, 04:23 PM |
Alenson Carman | Principal Accounting Officer | Feb 20, 2020 | Sale | $53.37 | 2,427 | 129,529 | 184 | Feb 24, 2020, 04:02 PM |
Alenson Carman | Principal Accounting Officer | Feb 18, 2020 | Option Exercise | $52.01 | 1,163 | 60,488 | 2,611 | Feb 19, 2020, 04:55 PM |
Bowden Christopher | Chief Medical Officer | Feb 18, 2020 | Option Exercise | $52.01 | 819 | 42,596 | 3,581 | Feb 19, 2020, 04:53 PM |
Hirsch Andrew | Chief Financial Officer | Feb 18, 2020 | Option Exercise | $52.01 | 886 | 46,081 | 14,241 | Feb 19, 2020, 04:51 PM |
Schenkein David P | Director | Feb 18, 2020 | Option Exercise | $52.01 | 2,534 | 131,793 | 103,158 | Feb 19, 2020, 04:50 PM |
Bowden Christopher | Chief Medical Officer | Feb 11, 2020 | Option Exercise | $35.16 | 621 | 21,834 | 2,271 | Feb 13, 2020, 04:21 PM |
Bowden Christopher | Chief Medical Officer | Feb 11, 2020 | Sale | $50.02 | 621 | 31,063 | 1,650 | Feb 13, 2020, 04:21 PM |
Bowden Christopher | Chief Medical Officer | Feb 05, 2020 | Option Exercise | $35.16 | 35,447 | 1,246,317 | 37,097 | Feb 06, 2020, 04:52 PM |
Bowden Christopher | Chief Medical Officer | Feb 04, 2020 | Option Exercise | $35.16 | 8,526 | 299,774 | 15,841 | Feb 06, 2020, 04:52 PM |
Bowden Christopher | Chief Medical Officer | Feb 04, 2020 | Sale | $50.08 | 49,638 | 2,485,989 | 1,650 | Feb 06, 2020, 04:52 PM |
Alenson Carman | Principal Accounting Officer | Dec 26, 2019 | Sale | $50.09 | 2,950 | 147,766 | 184 | Dec 30, 2019, 04:08 PM |
FOUSE JACQUALYN A | Chief Executive Officer | Nov 13, 2019 | Buy | $31.00 | 40,322 | 1,249,982 | 41,722 | Nov 15, 2019, 04:05 PM |
Schenkein David P | Director | Nov 13, 2019 | Buy | $31.00 | 8,064 | 249,984 | 97,567 | Nov 15, 2019, 04:03 PM |
CELGENE CORP /DE/ | 10% Owner | Nov 12, 2019 | Buy | $31.00 | 403,225 | 12,499,975 | 1,777,824 | Nov 14, 2019, 04:06 PM |
Biller Scott | Chief Scientific Officer | Jun 11, 2019 | Option Exercise | $2.34 | 7,218 | 16,872 | 33,729 | Jun 13, 2019, 04:07 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2019 | Option Exercise | $39.76 | 3,000 | 119,280 | 29,511 | Apr 09, 2019, 04:59 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2019 | Sale | $67.71 | 3,000 | 203,135 | 27,110 | Apr 09, 2019, 04:59 PM |
Bowden Christopher | Chief Medical Officer | Apr 01, 2019 | Option Exercise | $35.16 | 10,000 | 351,600 | 17,238 | Apr 03, 2019, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Apr 01, 2019 | Sale | $66.57 | 10,000 | 665,747 | 11,384 | Apr 03, 2019, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Mar 15, 2019 | Option Exercise | $35.16 | 10,000 | 351,600 | 17,238 | Mar 19, 2019, 04:25 PM |
Bowden Christopher | Chief Medical Officer | Mar 15, 2019 | Sale | $64.16 | 10,000 | 641,615 | 8,538 | Mar 19, 2019, 04:25 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2019 | Option Exercise | $38.60 | 3,000 | 115,805 | 29,511 | Mar 07, 2019, 04:06 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2019 | Sale | $67.68 | 3,000 | 203,032 | 29,311 | Mar 07, 2019, 04:06 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 01, 2019 | Option Exercise | $39.76 | 5,000 | 198,800 | 15,941 | Mar 05, 2019, 04:04 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 04, 2019 | Option Exercise | $39.76 | 5,000 | 198,800 | 15,941 | Mar 05, 2019, 04:04 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 04, 2019 | Sale | $68.00 | 5,000 | 340,000 | 10,941 | Mar 05, 2019, 04:04 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 01, 2019 | Sale | $66.01 | 5,000 | 330,050 | 10,941 | Mar 05, 2019, 04:04 PM |
Biller Scott | Chief Scientific Officer | Feb 27, 2019 | Option Exercise | $15.10 | 9,000 | 135,875 | 35,511 | Mar 01, 2019, 04:02 PM |
Biller Scott | Chief Scientific Officer | Feb 27, 2019 | Sale | $65.00 | 9,000 | 585,000 | 26,511 | Mar 01, 2019, 04:02 PM |
Alenson Carman | Principal Accounting Officer | Feb 21, 2019 | Option Exercise | $56.33 | 1,016 | 57,231 | 2,796 | Feb 25, 2019, 04:03 PM |
Schenkein David P | Director | Feb 19, 2019 | Option Exercise | $58.03 | 2,471 | 143,392 | 89,503 | Feb 20, 2019, 04:07 PM |
Hoerter Steven L. | Chief Commercial Officer | Feb 19, 2019 | Option Exercise | $58.03 | 1,040 | 60,351 | 10,941 | Feb 20, 2019, 04:06 PM |
Hirsch Andrew | Chief Financial Officer | Feb 19, 2019 | Option Exercise | $58.03 | 821 | 47,643 | 12,374 | Feb 20, 2019, 04:05 PM |
Bowden Christopher | Chief Medical Officer | Feb 19, 2019 | Option Exercise | $58.03 | 818 | 47,469 | 7,195 | Feb 20, 2019, 04:04 PM |
Biller Scott | Chief Scientific Officer | Feb 19, 2019 | Option Exercise | $58.03 | 876 | 50,834 | 26,511 | Feb 20, 2019, 04:03 PM |
Alenson Carman | Principal Accounting Officer | Feb 19, 2019 | Option Exercise | $58.03 | 278 | 16,132 | 512 | Feb 20, 2019, 04:01 PM |
Alenson Carman | Principal Accounting Officer | Sep 28, 2018 | Sale | $76.45 | 152 | 11,620 | 0 | Feb 20, 2019, 04:01 PM |
Hirsch Andrew | Chief Financial Officer | Jan 22, 2019 | Option Exercise | $52.82 | 4,555 | 240,595 | 10,445 | Jan 23, 2019, 04:22 PM |
Hoerter Steven L. | Chief Commercial Officer | Jan 22, 2019 | Option Exercise | $52.82 | 5,769 | 304,719 | 9,231 | Jan 23, 2019, 04:19 PM |
Bowden Christopher | Chief Medical Officer | Jan 22, 2019 | Option Exercise | $52.82 | 1,960 | 103,527 | 5,229 | Jan 23, 2019, 04:12 PM |
Biller Scott | Chief Scientific Officer | Dec 21, 2018 | Option Exercise | $2.34 | 20,500 | 47,919 | 24,637 | Dec 26, 2018, 04:39 PM |
Biller Scott | Chief Scientific Officer | Nov 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 53,932 | Nov 07, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Nov 05, 2018 | Sale | $69.69 | 3,000 | 209,071 | 51,732 | Nov 07, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Oct 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 53,932 | Oct 09, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Oct 05, 2018 | Sale | $69.79 | 3,000 | 209,377 | 53,032 | Oct 09, 2018, 04:09 PM |
MARAGANORE JOHN | Director | Sep 11, 2018 | Sale | $72.75 | 13,555 | 986,129 | 38,609 | Sep 13, 2018, 04:01 PM |
MARAGANORE JOHN | Director | Sep 12, 2018 | Sale | $71.74 | 14,162 | 1,015,982 | 22,047 | Sep 13, 2018, 04:01 PM |
Schenkein David P | Chief Executive Officer | Sep 10, 2018 | Option Exercise | $31.64 | 8,730 | 276,217 | 83,849 | Sep 12, 2018, 12:00 AM |
Schenkein David P | Chief Executive Officer | Sep 05, 2018 | Option Exercise | $3.32 | 75,119 | 249,028 | 75,119 | Sep 07, 2018, 04:22 PM |
Alenson Carman | Principal Accounting Officer | Sep 05, 2018 | Option Exercise | $52.29 | 312 | 16,314 | 464 | Sep 07, 2018, 04:18 PM |
Alenson Carman | Principal Accounting Officer | Sep 05, 2018 | Sale | $83.00 | 312 | 25,896 | 152 | Sep 07, 2018, 04:18 PM |
Biller Scott | Chief Scientific Officer | Sep 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Sep 07, 2018, 04:12 PM |
Biller Scott | Chief Scientific Officer | Sep 05, 2018 | Sale | $83.07 | 3,000 | 249,215 | 59,556 | Sep 07, 2018, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Aug 30, 2018 | Option Exercise | $35.16 | 1,700 | 59,772 | 2,624 | Aug 31, 2018, 04:02 PM |
Bowden Christopher | Chief Medical Officer | Aug 29, 2018 | Option Exercise | $35.16 | 300 | 10,548 | 1,224 | Aug 31, 2018, 04:02 PM |
Bowden Christopher | Chief Medical Officer | Aug 30, 2018 | Sale | $80.03 | 1,700 | 136,051 | 924 | Aug 31, 2018, 04:02 PM |
Bowden Christopher | Chief Medical Officer | Aug 29, 2018 | Sale | $80.00 | 300 | 24,000 | 924 | Aug 31, 2018, 04:02 PM |
Hoerter Steven L. | Chief Commercial Officer | Aug 24, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Aug 28, 2018, 04:06 PM |
Hoerter Steven L. | Chief Commercial Officer | Aug 24, 2018 | Sale | $74.92 | 2,050 | 153,586 | 0 | Aug 28, 2018, 04:06 PM |
Biller Scott | Chief Scientific Officer | Aug 06, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Aug 08, 2018, 04:14 PM |
Biller Scott | Chief Scientific Officer | Aug 06, 2018 | Sale | $80.11 | 3,000 | 240,333 | 59,896 | Aug 08, 2018, 04:14 PM |
Hoerter Steven L. | Chief Commercial Officer | Jul 25, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Jul 27, 2018, 04:01 PM |
Hoerter Steven L. | Chief Commercial Officer | Jul 25, 2018 | Sale | $84.58 | 2,050 | 173,389 | 0 | Jul 27, 2018, 04:01 PM |
Bowden Christopher | Chief Medical Officer | Jul 10, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,924 | Jul 12, 2018, 04:14 PM |
Bowden Christopher | Chief Medical Officer | Jul 10, 2018 | Sale | $86.76 | 2,000 | 173,512 | 1,724 | Jul 12, 2018, 04:14 PM |
Alenson Carman | Principal Accounting Officer | Jul 09, 2018 | Option Exercise | $52.29 | 272 | 14,223 | 272 | Jul 11, 2018, 04:23 PM |
Alenson Carman | Principal Accounting Officer | Jul 09, 2018 | Sale | $84.94 | 272 | 23,104 | 0 | Jul 11, 2018, 04:23 PM |
Biller Scott | Chief Scientific Officer | Jul 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Jul 09, 2018, 04:08 PM |
Biller Scott | Chief Scientific Officer | Jul 05, 2018 | Sale | $83.50 | 3,000 | 250,503 | 57,496 | Jul 09, 2018, 04:08 PM |
Hoerter Steven L. | Chief Commercial Officer | Jun 22, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Jun 26, 2018, 04:02 PM |
Hoerter Steven L. | Chief Commercial Officer | Jun 22, 2018 | Sale | $97.58 | 2,050 | 200,039 | 0 | Jun 26, 2018, 04:02 PM |
Foster-Cheek Kaye I | Director | Jun 14, 2018 | Option Exercise | $50.73 | 9,000 | 456,570 | 11,200 | Jun 18, 2018, 04:05 PM |
Foster-Cheek Kaye I | Director | Jun 14, 2018 | Sale | $93.55 | 9,000 | 841,926 | 9,019 | Jun 18, 2018, 04:05 PM |
Bowden Christopher | Chief Medical Officer | Jun 12, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Jun 14, 2018, 04:23 PM |
Bowden Christopher | Chief Medical Officer | Jun 12, 2018 | Sale | $92.89 | 2,000 | 185,786 | 1,081 | Jun 14, 2018, 04:23 PM |
Biller Scott | Chief Scientific Officer | Jun 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Jun 07, 2018, 04:02 PM |
Biller Scott | Chief Scientific Officer | Jun 05, 2018 | Sale | $93.37 | 3,000 | 280,101 | 59,394 | Jun 07, 2018, 04:02 PM |
Schenkein David P | Chief Executive Officer | Jun 01, 2018 | Option Exercise | $0.48 | 13,000 | 6,280 | 13,000 | Jun 05, 2018, 04:10 PM |
Schenkein David P | Chief Executive Officer | Jun 01, 2018 | Sale | $95.35 | 13,000 | 1,239,608 | 11,490 | Jun 05, 2018, 04:10 PM |
Schenkein David P | Chief Executive Officer | May 30, 2018 | Option Exercise | $0.39 | 45,626 | 17,675 | 45,626 | Jun 01, 2018, 04:08 PM |
Schenkein David P | Chief Executive Officer | May 30, 2018 | Sale | $90.07 | 45,626 | 4,109,534 | 0 | Jun 01, 2018, 04:08 PM |
Schenkein David P | Chief Executive Officer | May 23, 2018 | Option Exercise | $0.30 | 49,374 | 14,936 | 49,374 | May 29, 2018, 06:17 AM |
Schenkein David P | Chief Executive Officer | May 23, 2018 | Sale | $90.40 | 49,374 | 4,463,524 | 9,600 | May 29, 2018, 06:17 AM |
Hoerter Steven L. | Chief Commercial Officer | May 23, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | May 29, 2018, 06:14 AM |
Hoerter Steven L. | Chief Commercial Officer | May 23, 2018 | Sale | $85.76 | 2,050 | 175,808 | 0 | May 29, 2018, 06:14 AM |
Biller Scott | Chief Scientific Officer | May 23, 2018 | Option Exercise | $31.64 | 15,177 | 480,200 | 72,373 | May 29, 2018, 06:11 AM |
Biller Scott | Chief Scientific Officer | May 23, 2018 | Sale | $90.00 | 15,177 | 1,365,930 | 57,196 | May 29, 2018, 06:11 AM |
Bowden Christopher | Chief Medical Officer | May 11, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | May 15, 2018, 04:13 PM |
Bowden Christopher | Chief Medical Officer | May 11, 2018 | Sale | $85.00 | 2,000 | 170,003 | 2,041 | May 15, 2018, 04:13 PM |
Bowden Christopher | Chief Medical Officer | May 08, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | May 10, 2018, 04:00 PM |
Bowden Christopher | Chief Medical Officer | May 08, 2018 | Sale | $81.38 | 2,000 | 162,760 | 881 | May 10, 2018, 04:00 PM |
Biller Scott | Chief Scientific Officer | May 07, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | May 08, 2018, 04:08 PM |
Biller Scott | Chief Scientific Officer | May 07, 2018 | Sale | $81.81 | 3,000 | 245,430 | 57,196 | May 08, 2018, 04:08 PM |
Schenkein David P | Chief Executive Officer | May 01, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | May 03, 2018, 04:07 PM |
Schenkein David P | Chief Executive Officer | May 01, 2018 | Sale | $83.04 | 13,000 | 1,079,500 | 2,914 | May 03, 2018, 04:07 PM |
Hoerter Steven L. | Chief Commercial Officer | Apr 23, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Apr 25, 2018, 04:12 PM |
Hoerter Steven L. | Chief Commercial Officer | Apr 23, 2018 | Sale | $85.95 | 2,050 | 176,197 | 0 | Apr 25, 2018, 04:12 PM |
Bowden Christopher | Chief Medical Officer | Apr 12, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Apr 16, 2018, 04:01 PM |
Bowden Christopher | Chief Medical Officer | Apr 12, 2018 | Sale | $85.09 | 2,000 | 170,190 | 1,581 | Apr 16, 2018, 04:01 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 60,196 | Apr 09, 2018, 04:09 PM |
Biller Scott | Chief Scientific Officer | Apr 05, 2018 | Sale | $75.20 | 3,000 | 225,607 | 58,896 | Apr 09, 2018, 04:09 PM |
Schenkein David P | Chief Executive Officer | Apr 02, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | Apr 04, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Apr 02, 2018 | Sale | $77.72 | 13,000 | 1,010,357 | 11,443 | Apr 04, 2018, 04:03 PM |
Biller Scott | Chief Scientific Officer | Mar 28, 2018 | Option Exercise | $2.32 | 4,137 | 9,611 | 57,196 | Mar 30, 2018, 04:18 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 22, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Mar 26, 2018, 04:01 PM |
Hoerter Steven L. | Chief Commercial Officer | Mar 22, 2018 | Sale | $84.65 | 2,050 | 173,533 | 0 | Mar 26, 2018, 04:01 PM |
Foster-Cheek Kaye I | Director | Mar 19, 2018 | Option Exercise | $47.33 | 6,800 | 321,844 | 9,000 | Mar 21, 2018, 04:04 PM |
Foster-Cheek Kaye I | Director | Mar 19, 2018 | Sale | $81.97 | 6,800 | 557,396 | 2,200 | Mar 21, 2018, 04:04 PM |
Scadden David | Director | Mar 16, 2018 | Buy | $83.44 | 200 | 16,688 | 571 | Mar 20, 2018, 04:43 PM |
Bowden Christopher | Chief Medical Officer | Mar 14, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Mar 16, 2018, 04:50 PM |
Bowden Christopher | Chief Medical Officer | Mar 14, 2018 | Sale | $82.33 | 2,000 | 164,661 | 1,181 | Mar 16, 2018, 04:50 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2018 | Option Exercise | $9.05 | 3,000 | 27,150 | 56,059 | Mar 07, 2018, 04:10 PM |
Biller Scott | Chief Scientific Officer | Mar 05, 2018 | Sale | $83.08 | 3,000 | 249,229 | 55,659 | Mar 07, 2018, 04:10 PM |
Schenkein David P | Chief Executive Officer | Mar 01, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | Mar 05, 2018, 04:32 PM |
Schenkein David P | Chief Executive Officer | Mar 01, 2018 | Sale | $81.09 | 13,000 | 1,054,218 | 10,085 | Mar 05, 2018, 04:32 PM |
Foster-Cheek Kaye I | Director | Feb 26, 2018 | Option Exercise | $47.33 | 2,200 | 104,126 | 2,200 | Feb 28, 2018, 04:02 PM |
Hoerter Steven L. | Chief Commercial Officer | Feb 22, 2018 | Option Exercise | $39.76 | 2,050 | 81,508 | 2,050 | Feb 26, 2018, 04:45 PM |
Hoerter Steven L. | Chief Commercial Officer | Feb 22, 2018 | Sale | $78.63 | 2,050 | 161,191 | 0 | Feb 26, 2018, 04:45 PM |
Bowden Christopher | Chief Medical Officer | Feb 16, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Feb 20, 2018, 12:00 AM |
Bowden Christopher | Chief Medical Officer | Feb 16, 2018 | Sale | $77.65 | 2,000 | 155,305 | 1,381 | Feb 20, 2018, 12:00 AM |
Biller Scott | Chief Scientific Officer | Feb 05, 2018 | Option Exercise | $8.87 | 3,000 | 26,601 | 56,059 | Feb 07, 2018, 04:05 PM |
Biller Scott | Chief Scientific Officer | Feb 05, 2018 | Sale | $76.04 | 3,000 | 228,128 | 55,260 | Feb 07, 2018, 04:05 PM |
Bowden Christopher | Chief Medical Officer | Feb 01, 2018 | Option Exercise | $35.16 | 2,000 | 70,320 | 2,881 | Feb 05, 2018, 04:43 PM |
Bowden Christopher | Chief Medical Officer | Feb 01, 2018 | Sale | $78.75 | 2,000 | 157,500 | 1,566 | Feb 05, 2018, 04:43 PM |
Schenkein David P | Chief Executive Officer | Feb 01, 2018 | Option Exercise | $0.30 | 13,000 | 3,933 | 13,000 | Feb 05, 2018, 04:40 PM |
Schenkein David P | Chief Executive Officer | Feb 01, 2018 | Sale | $78.75 | 13,000 | 1,023,756 | 4,460 | Feb 05, 2018, 04:40 PM |
CELGENE CORP /DE/ | 10% Owner | Jan 23, 2018 | Buy | $67.00 | 851,154 | 57,027,318 | 1,374,599 | Jan 31, 2018, 08:39 AM |
Schenkein David P | Chief Executive Officer | Jan 26, 2018 | Option Exercise | $0.30 | 23,572 | 7,131 | 23,572 | Jan 30, 2018, 04:26 PM |
Schenkein David P | Chief Executive Officer | Jan 26, 2018 | Sale | $81.09 | 23,572 | 1,911,494 | 14,335 | Jan 30, 2018, 04:26 PM |
Alenson Carman | Principal Accounting Officer | Jan 12, 2018 | Option Exercise | $52.29 | 2,150 | 112,424 | 2,150 | Jan 26, 2018, 04:23 PM |
Alenson Carman | Principal Accounting Officer | Jan 12, 2018 | Sale | $75.00 | 2,150 | 161,250 | 0 | Jan 26, 2018, 04:23 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Option Exercise | $0.30 | 20 | 6 | 20 | Jan 26, 2018, 04:22 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Sale | $80.01 | 20 | 1,600 | 0 | Jan 26, 2018, 04:22 PM |
Hoerter Steven L. | Chief Commercial Officer | Jan 23, 2018 | Option Exercise | $39.76 | 25,000 | 994,000 | 25,000 | Jan 25, 2018, 04:03 PM |
Hoerter Steven L. | Chief Commercial Officer | Jan 23, 2018 | Sale | $74.83 | 25,000 | 1,870,750 | 0 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Option Exercise | $0.30 | 13,533 | 4,094 | 13,533 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 23, 2018 | Option Exercise | $0.30 | 32,875 | 9,945 | 32,875 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 24, 2018 | Sale | $80.01 | 13,533 | 1,082,775 | 0 | Jan 25, 2018, 04:03 PM |
Schenkein David P | Chief Executive Officer | Jan 23, 2018 | Sale | $80.01 | 32,875 | 2,630,329 | 0 | Jan 25, 2018, 04:03 PM |
CELGENE CORP /DE/ | 10% Owner | Jan 23, 2018 | Buy | $67.00 | 851,154 | 57,027,318 | 1,374,599 | Jan 23, 2018, 04:35 PM |
Schenkein David P | Chief Executive Officer | Jan 16, 2018 | Option Exercise | $0.30 | 53,000 | 16,033 | 53,000 | Jan 16, 2018, 05:16 PM |
Schenkein David P | Chief Executive Officer | Jan 16, 2018 | Sale | $73.16 | 53,000 | 3,877,218 | 39,815 | Jan 16, 2018, 05:16 PM |
Biller Scott | Chief Scientific Officer | Jan 10, 2018 | Option Exercise | $0.47 | 3,000 | 1,403 | 56,059 | Jan 12, 2018, 04:34 PM |
Biller Scott | Chief Scientific Officer | Jan 10, 2018 | Sale | $65.00 | 3,000 | 195,000 | 53,059 | Jan 12, 2018, 04:34 PM |
Cantley Lewis Clayton Jr. | Director | Dec 07, 2017 | Sale | $60.21 | 919 | 55,332 | 80,146 | Dec 08, 2017, 04:23 PM |
Cantley Lewis Clayton Jr. | Director | Dec 07, 2017 | Sale | $60.21 | 919 | 55,332 | 80,106 | Dec 08, 2017, 04:23 PM |
Cantley Lewis Clayton Jr. | Director | Dec 06, 2017 | Sale | $58.60 | 1,000 | 58,597 | 80,892 | Dec 08, 2017, 04:23 PM |
Cantley Lewis Clayton Jr. | Director | Dec 06, 2017 | Sale | $58.60 | 1,000 | 58,596 | 80,851 | Dec 08, 2017, 04:23 PM |
Biller Scott | Chief Scientific Officer | Dec 06, 2017 | Option Exercise | $1.74 | 46,795 | 81,376 | 53,059 | Dec 08, 2017, 04:22 PM |
Schenkein David P | Chief Executive Officer | Dec 01, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Dec 05, 2017, 04:28 PM |
Schenkein David P | Chief Executive Officer | Dec 01, 2017 | Sale | $61.55 | 6,000 | 369,288 | 400 | Dec 05, 2017, 04:28 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2017 | Option Exercise | $31.64 | 2,146 | 67,899 | 8,410 | Dec 05, 2017, 04:09 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2017 | Sale | $60.79 | 2,146 | 130,459 | 7,810 | Dec 05, 2017, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Nov 13, 2017 | Sale | $62.07 | 1,000 | 62,070 | 82,394 | Nov 15, 2017, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Nov 14, 2017 | Sale | $59.70 | 1,000 | 59,700 | 81,743 | Nov 15, 2017, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Nov 14, 2017 | Sale | $59.70 | 1,000 | 59,700 | 81,703 | Nov 15, 2017, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Nov 13, 2017 | Sale | $62.07 | 1,000 | 62,070 | 82,434 | Nov 15, 2017, 05:43 PM |
Biller Scott | Chief Scientific Officer | Nov 01, 2017 | Option Exercise | $31.64 | 2,146 | 67,899 | 8,410 | Nov 03, 2017, 04:01 PM |
Biller Scott | Chief Scientific Officer | Nov 01, 2017 | Sale | $62.69 | 2,146 | 134,522 | 8,310 | Nov 03, 2017, 04:01 PM |
Schenkein David P | Chief Executive Officer | Nov 01, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Nov 03, 2017, 04:00 PM |
Schenkein David P | Chief Executive Officer | Nov 01, 2017 | Sale | $63.85 | 6,000 | 383,105 | 5,800 | Nov 03, 2017, 04:00 PM |
Cantley Lewis Clayton Jr. | Director | Oct 16, 2017 | Sale | $71.09 | 1,000 | 71,090 | 84,434 | Oct 18, 2017, 05:34 PM |
Cantley Lewis Clayton Jr. | Director | Oct 16, 2017 | Sale | $71.09 | 1,000 | 71,090 | 84,394 | Oct 18, 2017, 05:34 PM |
Cantley Lewis Clayton Jr. | Director | Oct 17, 2017 | Sale | $71.10 | 1,000 | 71,100 | 83,434 | Oct 18, 2017, 05:34 PM |
Cantley Lewis Clayton Jr. | Director | Oct 17, 2017 | Sale | $71.10 | 1,000 | 71,100 | 83,394 | Oct 18, 2017, 05:34 PM |
Biller Scott | Chief Scientific Officer | Oct 04, 2017 | Sale | $70.00 | 10,470 | 732,900 | 0 | Oct 05, 2017, 06:35 PM |
Schenkein David P | Chief Executive Officer | Oct 04, 2017 | Option Exercise | $0.30 | 80,000 | 24,200 | 80,000 | Oct 05, 2017, 06:33 PM |
Schenkein David P | Chief Executive Officer | Oct 04, 2017 | Sale | $70.14 | 80,000 | 5,611,200 | 0 | Oct 05, 2017, 06:33 PM |
Biller Scott | Chief Scientific Officer | Oct 02, 2017 | Option Exercise | $19.10 | 2,146 | 40,995 | 7,455 | Oct 04, 2017, 04:32 PM |
Biller Scott | Chief Scientific Officer | Oct 02, 2017 | Sale | $67.23 | 2,146 | 144,276 | 6,264 | Oct 04, 2017, 04:32 PM |
Schenkein David P | Chief Executive Officer | Oct 02, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Oct 04, 2017, 04:29 PM |
Schenkein David P | Chief Executive Officer | Oct 02, 2017 | Sale | $66.76 | 6,000 | 400,560 | 0 | Oct 04, 2017, 04:29 PM |
Schenkein David P | Chief Executive Officer | Sep 18, 2017 | Option Exercise | $0.30 | 35,000 | 10,588 | 35,000 | Sep 20, 2017, 12:00 AM |
Schenkein David P | Chief Executive Officer | Sep 18, 2017 | Sale | $67.12 | 35,000 | 2,349,200 | 0 | Sep 20, 2017, 12:00 AM |
Cantley Lewis Clayton Jr. | Director | Sep 13, 2017 | Sale | $65.47 | 1,000 | 65,470 | 86,434 | Sep 15, 2017, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Sep 13, 2017 | Sale | $65.47 | 1,000 | 65,470 | 86,394 | Sep 15, 2017, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Sep 14, 2017 | Sale | $65.71 | 1,000 | 65,710 | 85,434 | Sep 15, 2017, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Sep 14, 2017 | Sale | $65.71 | 1,000 | 65,710 | 85,394 | Sep 15, 2017, 04:54 PM |
Bowden Christopher | Chief Medical Officer | Sep 11, 2017 | Option Exercise | $35.16 | 6,000 | 210,960 | 6,881 | Sep 13, 2017, 04:38 PM |
Bowden Christopher | Chief Medical Officer | Sep 11, 2017 | Sale | $65.00 | 6,000 | 390,000 | 881 | Sep 13, 2017, 04:38 PM |
Biller Scott | Chief Scientific Officer | Sep 11, 2017 | Sale | $65.00 | 15,000 | 975,000 | 10,470 | Sep 13, 2017, 04:37 PM |
Biller Scott | Chief Scientific Officer | Sep 01, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 8,410 | Sep 05, 2017, 05:25 PM |
Biller Scott | Chief Scientific Officer | Sep 01, 2017 | Sale | $61.99 | 2,146 | 133,031 | 6,264 | Sep 05, 2017, 05:25 PM |
Schenkein David P | Chief Executive Officer | Sep 01, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Sep 05, 2017, 05:22 PM |
Schenkein David P | Chief Executive Officer | Sep 01, 2017 | Sale | $62.20 | 6,000 | 373,200 | 0 | Sep 05, 2017, 05:22 PM |
Cantley Lewis Clayton Jr. | Director | Aug 23, 2017 | Sale | $57.08 | 1,000 | 57,080 | 87,934 | Aug 24, 2017, 04:13 PM |
Cantley Lewis Clayton Jr. | Director | Aug 23, 2017 | Sale | $57.08 | 1,000 | 57,080 | 87,894 | Aug 24, 2017, 04:13 PM |
Cantley Lewis Clayton Jr. | Director | Aug 22, 2017 | Sale | $56.62 | 1,000 | 56,620 | 88,934 | Aug 24, 2017, 04:13 PM |
Cantley Lewis Clayton Jr. | Director | Aug 22, 2017 | Sale | $56.62 | 1,000 | 56,620 | 88,894 | Aug 24, 2017, 04:13 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 8,410 | Aug 03, 2017, 05:29 PM |
Biller Scott | Chief Scientific Officer | Aug 02, 2017 | Sale | $60.06 | 21,000 | 1,261,260 | 25,470 | Aug 03, 2017, 05:29 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2017 | Sale | $55.05 | 2,146 | 118,137 | 6,264 | Aug 03, 2017, 05:29 PM |
Schenkein David P | Chief Executive Officer | Aug 01, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | Aug 03, 2017, 05:26 PM |
Schenkein David P | Chief Executive Officer | Aug 02, 2017 | Option Exercise | $0.30 | 24,000 | 7,260 | 24,000 | Aug 03, 2017, 05:26 PM |
Schenkein David P | Chief Executive Officer | Aug 02, 2017 | Sale | $60.55 | 24,000 | 1,453,200 | 0 | Aug 03, 2017, 05:26 PM |
Schenkein David P | Chief Executive Officer | Aug 01, 2017 | Sale | $55.12 | 3,000 | 165,360 | 0 | Aug 03, 2017, 05:26 PM |
Cantley Lewis Clayton Jr. | Director | Jul 20, 2017 | Sale | $57.13 | 1,000 | 57,125 | 85,737 | Jul 21, 2017, 04:05 PM |
Cantley Lewis Clayton Jr. | Director | Jul 20, 2017 | Sale | $57.13 | 1,000 | 57,125 | 85,697 | Jul 21, 2017, 04:05 PM |
Cantley Lewis Clayton Jr. | Director | Jul 19, 2017 | Sale | $56.14 | 3,500 | 196,505 | 86,737 | Jul 21, 2017, 04:05 PM |
Cantley Lewis Clayton Jr. | Director | Jul 19, 2017 | Sale | $56.14 | 3,500 | 196,505 | 86,697 | Jul 21, 2017, 04:05 PM |
Biller Scott | Chief Scientific Officer | Jul 07, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 8,410 | Jul 11, 2017, 04:07 PM |
Biller Scott | Chief Scientific Officer | Jul 07, 2017 | Sale | $55.00 | 2,146 | 118,030 | 6,264 | Jul 11, 2017, 04:07 PM |
Schenkein David P | Chief Executive Officer | Jul 03, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | Jul 06, 2017, 04:31 PM |
Schenkein David P | Chief Executive Officer | Jul 03, 2017 | Sale | $51.18 | 3,000 | 153,540 | 0 | Jul 06, 2017, 04:31 PM |
Biller Scott | Chief Scientific Officer | Jun 23, 2017 | Option Exercise | $0.47 | 3,000 | 1,403 | 6,264 | Jun 27, 2017, 04:33 PM |
Biller Scott | Chief Scientific Officer | Jun 21, 2017 | Option Exercise | $5.52 | 7,292 | 40,245 | 4,556 | Jun 23, 2017, 04:08 PM |
Biller Scott | Chief Scientific Officer | Jun 21, 2017 | Sale | $55.00 | 4,292 | 236,060 | 264 | Jun 23, 2017, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Jun 14, 2017 | Sale | $51.09 | 500 | 25,545 | 89,697 | Jun 15, 2017, 05:02 PM |
Cantley Lewis Clayton Jr. | Director | Jun 13, 2017 | Sale | $50.64 | 500 | 25,320 | 90,237 | Jun 15, 2017, 05:02 PM |
Cantley Lewis Clayton Jr. | Director | Jun 13, 2017 | Sale | $50.64 | 500 | 25,320 | 90,197 | Jun 15, 2017, 05:02 PM |
Cantley Lewis Clayton Jr. | Director | Jun 14, 2017 | Sale | $51.09 | 500 | 25,545 | 89,737 | Jun 15, 2017, 05:02 PM |
Schenkein David P | Chief Executive Officer | Jun 06, 2017 | Option Exercise | $0.30 | 1,100 | 333 | 1,100 | Jun 08, 2017, 04:06 PM |
Schenkein David P | Chief Executive Officer | Jun 07, 2017 | Option Exercise | $0.30 | 1,900 | 575 | 1,900 | Jun 08, 2017, 04:06 PM |
Schenkein David P | Chief Executive Officer | Jun 07, 2017 | Sale | $50.02 | 1,900 | 95,038 | 0 | Jun 08, 2017, 04:06 PM |
Schenkein David P | Chief Executive Officer | Jun 06, 2017 | Sale | $50.02 | 1,100 | 55,022 | 0 | Jun 08, 2017, 04:06 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2017 | Sale | $46.92 | 509 | 23,882 | 90,737 | May 25, 2017, 07:03 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2017 | Sale | $46.92 | 509 | 23,882 | 90,697 | May 25, 2017, 07:03 PM |
Cantley Lewis Clayton Jr. | Director | May 24, 2017 | Sale | $47.27 | 509 | 24,060 | 91,246 | May 25, 2017, 07:03 PM |
Cantley Lewis Clayton Jr. | Director | May 24, 2017 | Sale | $47.27 | 509 | 24,060 | 91,206 | May 25, 2017, 07:03 PM |
Schenkein David P | Chief Executive Officer | May 01, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | May 02, 2017, 04:03 PM |
Schenkein David P | Chief Executive Officer | May 01, 2017 | Sale | $50.06 | 3,000 | 150,180 | 0 | May 02, 2017, 04:03 PM |
Celgene European Investment Co LLC | 10% Owner | Apr 24, 2017 | Buy | $49.50 | 624,575 | 30,916,463 | 1,856,353 | Apr 24, 2017, 04:34 PM |
Cantley Lewis Clayton Jr. | Director | Apr 18, 2017 | Sale | $50.92 | 509 | 25,918 | 91,755 | Apr 19, 2017, 05:16 PM |
Cantley Lewis Clayton Jr. | Director | Apr 18, 2017 | Sale | $50.92 | 509 | 25,918 | 91,715 | Apr 19, 2017, 05:16 PM |
Cantley Lewis Clayton Jr. | Director | Apr 17, 2017 | Sale | $55.24 | 2,036 | 112,458 | 93,791 | Apr 19, 2017, 05:16 PM |
Cantley Lewis Clayton Jr. | Director | Apr 17, 2017 | Sale | $55.24 | 2,036 | 112,458 | 93,751 | Apr 19, 2017, 05:16 PM |
Biller Scott | Chief Scientific Officer | Apr 03, 2017 | Option Exercise | $9.05 | 2,146 | 19,421 | 17,880 | Apr 05, 2017, 04:05 PM |
Biller Scott | Chief Scientific Officer | Apr 03, 2017 | Sale | $58.03 | 2,146 | 124,532 | 15,734 | Apr 05, 2017, 04:05 PM |
Schenkein David P | Chief Executive Officer | Apr 03, 2017 | Option Exercise | $0.30 | 3,000 | 908 | 3,000 | Apr 05, 2017, 04:04 PM |
Schenkein David P | Chief Executive Officer | Apr 03, 2017 | Sale | $58.62 | 3,000 | 175,860 | 0 | Apr 05, 2017, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 23, 2017 | Sale | $53.91 | 509 | 27,440 | 94,300 | Mar 24, 2017, 04:20 PM |
Cantley Lewis Clayton Jr. | Director | Mar 23, 2017 | Sale | $53.91 | 509 | 27,440 | 94,260 | Mar 24, 2017, 04:20 PM |
Cantley Lewis Clayton Jr. | Director | Mar 22, 2017 | Sale | $52.31 | 509 | 26,626 | 94,809 | Mar 24, 2017, 04:20 PM |
Cantley Lewis Clayton Jr. | Director | Mar 22, 2017 | Sale | $52.31 | 509 | 26,626 | 94,769 | Mar 24, 2017, 04:20 PM |
Biller Scott | Chief Scientific Officer | Mar 20, 2017 | Option Exercise | $8.38 | 6,438 | 53,930 | 21,403 | Mar 22, 2017, 05:10 PM |
Biller Scott | Chief Scientific Officer | Mar 20, 2017 | Sale | $55.00 | 6,438 | 354,090 | 15,470 | Mar 22, 2017, 05:10 PM |
NELSEN ROBERT | Director | Mar 06, 2017 | Sale | $49.43 | 40 | 1,977 | 0 | Mar 07, 2017, 04:35 PM |
NELSEN ROBERT | Director | Mar 03, 2017 | Sale | $50.85 | 40,559 | 2,062,232 | 9,174 | Mar 07, 2017, 04:35 PM |
NELSEN ROBERT | Director | Feb 28, 2017 | Sale | $49.77 | 47,859 | 2,381,815 | 60,836 | Mar 01, 2017, 05:37 PM |
NELSEN ROBERT | Director | Feb 27, 2017 | Sale | $49.26 | 195,223 | 9,616,080 | 229,696 | Mar 01, 2017, 05:37 PM |
NELSEN ROBERT | Director | Feb 22, 2017 | Sale | $49.91 | 47,938 | 2,392,754 | 335,677 | Feb 23, 2017, 07:20 PM |
NELSEN ROBERT | Director | Feb 21, 2017 | Sale | $50.73 | 36,430 | 1,848,249 | 417,265 | Feb 23, 2017, 07:20 PM |
NELSEN ROBERT | Director | Feb 23, 2017 | Sale | $47.90 | 50,996 | 2,442,461 | 292,081 | Feb 23, 2017, 07:20 PM |
Schenkein David P | Chief Executive Officer | Feb 16, 2017 | Option Exercise | $0.30 | 6,000 | 1,815 | 6,000 | Feb 17, 2017, 04:36 PM |
Schenkein David P | Chief Executive Officer | Feb 16, 2017 | Sale | $50.01 | 6,000 | 300,060 | 0 | Feb 17, 2017, 04:36 PM |
Biller Scott | Chief Scientific Officer | Nov 14, 2016 | Option Exercise | $12.26 | 27,500 | 337,037 | 75,770 | Nov 16, 2016, 04:52 PM |
Biller Scott | Chief Scientific Officer | Nov 14, 2016 | Sale | $65.00 | 5,000 | 325,000 | 6,000 | Nov 16, 2016, 04:52 PM |
Biller Scott | Chief Scientific Officer | Nov 14, 2016 | Sale | $65.00 | 27,500 | 1,787,500 | 48,270 | Nov 16, 2016, 04:52 PM |
Biller Scott | Chief Scientific Officer | Nov 10, 2016 | Sale | $60.00 | 2,128 | 127,680 | 11,000 | Nov 14, 2016, 06:07 PM |
Biller Scott | Chief Scientific Officer | Nov 09, 2016 | Sale | $60.00 | 2,872 | 172,320 | 13,128 | Nov 14, 2016, 06:07 PM |
Cantley Lewis Clayton Jr. | Director | Oct 27, 2016 | Sale | $48.97 | 625 | 30,606 | 107,818 | Oct 28, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | Oct 27, 2016 | Sale | $48.97 | 627 | 30,704 | 107,778 | Oct 28, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | Oct 26, 2016 | Sale | $48.91 | 625 | 30,569 | 108,443 | Oct 28, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | Oct 26, 2016 | Sale | $48.91 | 627 | 30,667 | 108,405 | Oct 28, 2016, 04:03 PM |
Biller Scott | Chief Scientific Officer | Oct 05, 2016 | Sale | $55.00 | 5,000 | 275,000 | 16,000 | Oct 06, 2016, 04:14 PM |
Cantley Lewis Clayton Jr. | Director | Sep 28, 2016 | Sale | $54.00 | 625 | 33,750 | 109,068 | Sep 28, 2016, 05:29 PM |
Cantley Lewis Clayton Jr. | Director | Sep 28, 2016 | Sale | $54.00 | 627 | 33,858 | 109,032 | Sep 28, 2016, 05:29 PM |
Cantley Lewis Clayton Jr. | Director | Sep 27, 2016 | Sale | $54.15 | 625 | 33,844 | 109,693 | Sep 28, 2016, 05:29 PM |
Cantley Lewis Clayton Jr. | Director | Sep 27, 2016 | Sale | $54.15 | 627 | 33,952 | 109,659 | Sep 28, 2016, 05:29 PM |
Biller Scott | Chief Scientific Officer | Sep 20, 2016 | Sale | $50.00 | 5,000 | 250,000 | 21,000 | Sep 22, 2016, 04:40 PM |
Cantley Lewis Clayton Jr. | Director | Aug 30, 2016 | Sale | $36.81 | 625 | 23,006 | 110,318 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Aug 30, 2016 | Sale | $36.81 | 627 | 23,080 | 110,286 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Aug 29, 2016 | Sale | $37.81 | 625 | 23,631 | 110,943 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Aug 29, 2016 | Sale | $37.81 | 627 | 23,707 | 110,913 | Aug 31, 2016, 04:02 PM |
Cantley Lewis Clayton Jr. | Director | Jul 25, 2016 | Sale | $41.85 | 625 | 26,156 | 112,193 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jul 25, 2016 | Sale | $41.85 | 627 | 26,240 | 112,167 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jul 26, 2016 | Sale | $43.74 | 625 | 27,338 | 111,568 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jul 26, 2016 | Sale | $43.74 | 627 | 27,425 | 111,540 | Jul 27, 2016, 04:28 PM |
Cantley Lewis Clayton Jr. | Director | Jun 28, 2016 | Sale | $43.38 | 625 | 27,113 | 125,318 | Jun 29, 2016, 05:05 PM |
Cantley Lewis Clayton Jr. | Director | Jun 28, 2016 | Sale | $43.38 | 627 | 27,199 | 125,294 | Jun 29, 2016, 05:05 PM |
Cantley Lewis Clayton Jr. | Director | Jun 27, 2016 | Sale | $40.37 | 625 | 25,231 | 125,943 | Jun 29, 2016, 05:05 PM |
Cantley Lewis Clayton Jr. | Director | Jun 27, 2016 | Sale | $40.37 | 627 | 25,312 | 125,921 | Jun 29, 2016, 05:05 PM |
Biller Scott | Chief Scientific Officer | Jun 08, 2016 | Option Exercise | $6.36 | 27,500 | 174,766 | 86,570 | Jun 10, 2016, 04:03 PM |
Biller Scott | Chief Scientific Officer | Jun 10, 2016 | Option Exercise | $0.47 | 15,200 | 7,106 | 74,270 | Jun 10, 2016, 04:03 PM |
Biller Scott | Chief Scientific Officer | Jun 08, 2016 | Sale | $65.00 | 27,500 | 1,787,500 | 59,070 | Jun 10, 2016, 04:03 PM |
Cantley Lewis Clayton Jr. | Director | May 26, 2016 | Sale | $52.88 | 625 | 33,050 | 126,568 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | May 26, 2016 | Sale | $52.88 | 627 | 33,156 | 126,548 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2016 | Sale | $50.50 | 625 | 31,563 | 127,193 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | May 25, 2016 | Sale | $50.50 | 627 | 31,664 | 127,175 | May 27, 2016, 04:18 PM |
Cantley Lewis Clayton Jr. | Director | Apr 26, 2016 | Sale | $51.88 | 625 | 32,425 | 127,818 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Apr 26, 2016 | Sale | $51.88 | 627 | 32,529 | 127,802 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Apr 25, 2016 | Sale | $55.00 | 625 | 34,375 | 128,443 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Apr 25, 2016 | Sale | $55.00 | 627 | 34,485 | 128,429 | Apr 27, 2016, 04:08 PM |
Cantley Lewis Clayton Jr. | Director | Mar 29, 2016 | Sale | $36.28 | 627 | 22,748 | 129,683 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 30, 2016 | Sale | $38.09 | 625 | 23,806 | 129,068 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 30, 2016 | Sale | $38.09 | 627 | 23,882 | 129,056 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Mar 29, 2016 | Sale | $36.28 | 625 | 22,675 | 129,693 | Mar 31, 2016, 04:04 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.98 | 3,492 | 209,450 | 138,150 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.99 | 3,490 | 209,365 | 138,150 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.58 | 1,360 | 81,029 | 141,642 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.59 | 1,362 | 81,162 | 141,640 | Mar 23, 2016, 04:24 PM |
Cantley Lewis Clayton Jr. | Director | Feb 25, 2016 | Sale | $36.90 | 625 | 23,063 | 131,090 | Feb 29, 2016, 04:17 PM |
Cantley Lewis Clayton Jr. | Director | Feb 25, 2016 | Sale | $36.90 | 627 | 23,136 | 131,086 | Feb 29, 2016, 04:17 PM |
Cantley Lewis Clayton Jr. | Director | Feb 26, 2016 | Sale | $38.89 | 625 | 24,306 | 130,465 | Feb 29, 2016, 04:17 PM |
Cantley Lewis Clayton Jr. | Director | Feb 26, 2016 | Sale | $38.89 | 627 | 24,384 | 130,459 | Feb 29, 2016, 04:17 PM |
Biller Scott | Chief Scientific Officer | Feb 03, 2016 | Option Exercise | $0.47 | 10,000 | 4,675 | 59,070 | Feb 10, 2016, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Jan 28, 2016 | Sale | $44.33 | 627 | 27,795 | 132,340 | Feb 01, 2016, 05:56 PM |
Cantley Lewis Clayton Jr. | Director | Jan 29, 2016 | Sale | $41.52 | 625 | 25,950 | 131,715 | Feb 01, 2016, 05:56 PM |
Cantley Lewis Clayton Jr. | Director | Jan 29, 2016 | Sale | $41.52 | 627 | 26,033 | 131,713 | Feb 01, 2016, 05:56 PM |
Cantley Lewis Clayton Jr. | Director | Jan 28, 2016 | Sale | $44.33 | 625 | 27,706 | 132,340 | Feb 01, 2016, 05:56 PM |
Biller Scott | Chief Scientific Officer | Jan 07, 2016 | Option Exercise | $0.47 | 15,000 | 7,013 | 49,070 | Jan 11, 2016, 04:23 PM |
Schenkein David P | Chief Executive Officer | Jan 07, 2016 | Option Exercise | $0.30 | 20,000 | 6,050 | 272,272 | Jan 11, 2016, 04:22 PM |
Biller Scott | Chief Scientific Officer | Dec 31, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Jan 05, 2016, 05:21 PM |
Biller Scott | Chief Scientific Officer | Dec 31, 2015 | Sale | $65.27 | 5,500 | 358,985 | 34,070 | Jan 05, 2016, 05:21 PM |
Higgons John Duncan | Chief Operating Officer | Jan 04, 2016 | Option Exercise | $3.32 | 58,999 | 195,925 | 120,834 | Jan 05, 2016, 05:20 PM |
Schenkein David P | Chief Executive Officer | Jan 04, 2016 | Option Exercise | $0.30 | 10,000 | 3,025 | 242,272 | Jan 05, 2016, 05:17 PM |
Schenkein David P | Chief Executive Officer | Jan 05, 2016 | Option Exercise | $0.30 | 10,000 | 3,025 | 252,272 | Jan 05, 2016, 05:17 PM |
Cantley Lewis Clayton Jr. | Director | Dec 29, 2015 | Sale | $66.16 | 2,670 | 176,647 | 132,967 | Dec 29, 2015, 08:20 PM |
Cantley Lewis Clayton Jr. | Director | Dec 28, 2015 | Sale | $63.72 | 2,662 | 169,623 | 135,635 | Dec 29, 2015, 08:20 PM |
Cantley Lewis Clayton Jr. | Director | Dec 28, 2015 | Sale | $63.73 | 2,662 | 169,649 | 135,637 | Dec 29, 2015, 08:20 PM |
Cantley Lewis Clayton Jr. | Director | Dec 29, 2015 | Sale | $66.11 | 2,670 | 176,514 | 132,965 | Dec 29, 2015, 08:20 PM |
Higgons John Duncan | Chief Operating Officer | Dec 15, 2015 | Sale | $50.09 | 20,000 | 1,001,800 | 61,835 | Dec 17, 2015, 04:02 PM |
Biller Scott | Chief Scientific Officer | Nov 30, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Dec 02, 2015, 04:11 PM |
Biller Scott | Chief Scientific Officer | Nov 30, 2015 | Sale | $65.99 | 5,500 | 362,945 | 34,070 | Dec 02, 2015, 04:11 PM |
Higgons John Duncan | Chief Operating Officer | Nov 16, 2015 | Option Exercise | $1.09 | 20,000 | 21,764 | 101,835 | Nov 18, 2015, 04:19 PM |
Higgons John Duncan | Chief Operating Officer | Nov 16, 2015 | Sale | $61.51 | 20,000 | 1,230,200 | 81,835 | Nov 18, 2015, 04:19 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.98 | 3,492 | 209,450 | 138,297 | Nov 18, 2015, 04:15 PM |
Cantley Lewis Clayton Jr. | Director | Nov 17, 2015 | Sale | $59.99 | 3,490 | 209,365 | 138,299 | Nov 18, 2015, 04:15 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.38 | 1,213 | 72,028 | 141,789 | Nov 18, 2015, 04:15 PM |
Cantley Lewis Clayton Jr. | Director | Nov 16, 2015 | Sale | $59.38 | 1,213 | 72,028 | 141,789 | Nov 18, 2015, 04:15 PM |
Biller Scott | Chief Scientific Officer | Nov 02, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Nov 03, 2015, 05:46 PM |
Biller Scott | Chief Scientific Officer | Nov 02, 2015 | Sale | $77.12 | 5,500 | 424,160 | 34,070 | Nov 03, 2015, 05:46 PM |
Schenkein David P | Chief Executive Officer | Oct 27, 2015 | Option Exercise | $31.64 | 4,000 | 126,560 | 236,272 | Oct 30, 2015, 10:52 AM |
Schenkein David P | Chief Executive Officer | Oct 27, 2015 | Sale | $80.26 | 4,000 | 321,040 | 232,272 | Oct 30, 2015, 10:52 AM |
Cantley Lewis Clayton Jr. | Director | Oct 22, 2015 | Sale | $61.21 | 2,426 | 148,495 | 145,428 | Oct 27, 2015, 09:14 AM |
Cantley Lewis Clayton Jr. | Director | Oct 23, 2015 | Sale | $61.10 | 2,426 | 148,229 | 143,002 | Oct 27, 2015, 09:14 AM |
Cantley Lewis Clayton Jr. | Director | Oct 23, 2015 | Sale | $61.11 | 2,426 | 148,253 | 143,002 | Oct 27, 2015, 09:14 AM |
Cantley Lewis Clayton Jr. | Director | Oct 22, 2015 | Sale | $61.22 | 2,426 | 148,520 | 145,428 | Oct 27, 2015, 09:14 AM |
Higgons John Duncan | Chief Operating Officer | Oct 15, 2015 | Option Exercise | $0.31 | 20,000 | 6,244 | 101,835 | Oct 19, 2015, 05:35 PM |
Higgons John Duncan | Chief Operating Officer | Oct 15, 2015 | Sale | $71.04 | 20,000 | 1,420,800 | 81,835 | Oct 19, 2015, 05:35 PM |
Higgons John Duncan | Chief Operating Officer | Sep 30, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 151,835 | Oct 02, 2015, 04:11 PM |
Biller Scott | Chief Scientific Officer | Sep 30, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Oct 02, 2015, 04:05 PM |
Biller Scott | Chief Scientific Officer | Sep 30, 2015 | Sale | $70.44 | 5,500 | 387,420 | 34,070 | Oct 02, 2015, 04:05 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 24, 2015 | Option Exercise | $88.89 | 4,856 | 431,650 | 5,144 | Sep 28, 2015, 05:15 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 24, 2015 | Option Exercise | $23.10 | 856 | 19,774 | 6,000 | Sep 28, 2015, 05:15 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 24, 2015 | Sale | $85.97 | 6,000 | 515,820 | 0 | Sep 28, 2015, 05:15 PM |
Cantley Lewis Clayton Jr. | Director | Sep 24, 2015 | Sale | $84.43 | 2,426 | 204,827 | 150,280 | Sep 28, 2015, 05:13 PM |
Cantley Lewis Clayton Jr. | Director | Sep 25, 2015 | Sale | $82.07 | 2,426 | 199,102 | 147,854 | Sep 28, 2015, 05:13 PM |
Cantley Lewis Clayton Jr. | Director | Sep 25, 2015 | Sale | $82.09 | 2,426 | 199,150 | 147,854 | Sep 28, 2015, 05:13 PM |
Cantley Lewis Clayton Jr. | Director | Sep 24, 2015 | Sale | $84.42 | 2,426 | 204,803 | 150,280 | Sep 28, 2015, 05:13 PM |
Higgons John Duncan | Chief Operating Officer | Sep 15, 2015 | Option Exercise | $0.30 | 20,000 | 6,050 | 161,835 | Sep 17, 2015, 06:39 PM |
Higgons John Duncan | Chief Operating Officer | Sep 15, 2015 | Sale | $91.11 | 20,000 | 1,822,200 | 141,835 | Sep 17, 2015, 06:39 PM |
Higgons John Duncan | Chief Operating Officer | Aug 20, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 141,835 | Aug 21, 2015, 04:56 PM |
Higgons John Duncan | Chief Operating Officer | Aug 17, 2015 | Option Exercise | $0.30 | 20,000 | 6,050 | 151,835 | Aug 19, 2015, 04:11 PM |
Higgons John Duncan | Chief Operating Officer | Aug 17, 2015 | Sale | $92.24 | 20,000 | 1,844,800 | 131,835 | Aug 19, 2015, 04:11 PM |
Cantley Lewis Clayton Jr. | Director | Aug 18, 2015 | Sale | $95.69 | 2,426 | 232,144 | 152,706 | Aug 19, 2015, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Aug 18, 2015 | Sale | $95.69 | 2,426 | 232,144 | 152,706 | Aug 19, 2015, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Aug 17, 2015 | Sale | $94.18 | 2,426 | 228,481 | 155,132 | Aug 19, 2015, 04:09 PM |
Cantley Lewis Clayton Jr. | Director | Aug 17, 2015 | Sale | $94.21 | 2,426 | 228,553 | 155,132 | Aug 19, 2015, 04:09 PM |
Biller Scott | Chief Scientific Officer | Aug 10, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Aug 12, 2015, 05:02 PM |
Biller Scott | Chief Scientific Officer | Aug 10, 2015 | Sale | $100.00 | 5,500 | 550,000 | 34,070 | Aug 12, 2015, 05:02 PM |
Higgons John Duncan | Chief Operating Officer | Aug 06, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 131,835 | Aug 10, 2015, 05:19 PM |
Schenkein David P | Chief Executive Officer | Aug 03, 2015 | Option Exercise | $28.89 | 8,000 | 231,152 | 240,272 | Aug 05, 2015, 05:11 PM |
Schenkein David P | Chief Executive Officer | Aug 03, 2015 | Sale | $110.60 | 8,000 | 884,800 | 232,272 | Aug 05, 2015, 05:11 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 23, 2015 | Option Exercise | $30.03 | 7,000 | 210,216 | 7,000 | Jul 27, 2015, 05:36 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 23, 2015 | Sale | $120.45 | 7,000 | 843,150 | 0 | Jul 27, 2015, 05:36 PM |
Biller Scott | Chief Scientific Officer | Jul 20, 2015 | Option Exercise | $31.64 | 5,500 | 174,020 | 39,570 | Jul 22, 2015, 06:30 PM |
Biller Scott | Chief Scientific Officer | Jul 20, 2015 | Sale | $113.87 | 5,500 | 626,285 | 34,070 | Jul 22, 2015, 06:30 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 17, 2015 | Option Exercise | $5.89 | 13,000 | 76,603 | 13,000 | Jul 21, 2015, 06:41 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 17, 2015 | Sale | $113.71 | 13,000 | 1,478,230 | 0 | Jul 21, 2015, 06:41 PM |
Cantley Lewis Clayton Jr. | Director | Jul 16, 2015 | Sale | $114.17 | 2,426 | 276,976 | 157,558 | Jul 17, 2015, 05:01 PM |
Cantley Lewis Clayton Jr. | Director | Jul 15, 2015 | Sale | $114.35 | 2,426 | 277,413 | 159,984 | Jul 17, 2015, 05:01 PM |
Cantley Lewis Clayton Jr. | Director | Jul 15, 2015 | Sale | $114.38 | 2,426 | 277,486 | 159,984 | Jul 17, 2015, 05:01 PM |
Cantley Lewis Clayton Jr. | Director | Jul 16, 2015 | Sale | $114.20 | 2,426 | 277,049 | 157,558 | Jul 17, 2015, 05:01 PM |
Higgons John Duncan | Chief Operating Officer | Jul 16, 2015 | Option Exercise | $0.30 | 20,000 | 6,050 | 141,835 | Jul 17, 2015, 04:46 PM |
Higgons John Duncan | Chief Operating Officer | Jul 16, 2015 | Sale | $114.02 | 20,000 | 2,280,400 | 121,835 | Jul 17, 2015, 04:46 PM |
Biller Scott | Chief Scientific Officer | May 07, 2015 | Sale | $96.32 | 5,500 | 529,760 | 34,070 | Jul 08, 2015, 04:04 PM |
Biller Scott | Chief Scientific Officer | Apr 08, 2015 | Sale | $97.64 | 5,500 | 537,020 | 39,570 | Jul 08, 2015, 04:04 PM |
Biller Scott | Chief Scientific Officer | Jun 26, 2015 | Option Exercise | $0.47 | 7,500 | 3,506 | 45,070 | Jun 30, 2015, 05:48 PM |
Cantley Lewis Clayton Jr. | Director | Jun 24, 2015 | Sale | $104.60 | 2,426 | 253,760 | 164,836 | Jun 25, 2015, 06:22 PM |
Cantley Lewis Clayton Jr. | Director | Jun 25, 2015 | Sale | $105.66 | 2,426 | 256,331 | 162,410 | Jun 25, 2015, 06:22 PM |
Cantley Lewis Clayton Jr. | Director | Jun 25, 2015 | Sale | $105.66 | 2,426 | 256,331 | 162,410 | Jun 25, 2015, 06:22 PM |
Cantley Lewis Clayton Jr. | Director | Jun 24, 2015 | Sale | $104.59 | 2,426 | 253,735 | 164,836 | Jun 25, 2015, 06:22 PM |
Biller Scott | Chief Scientific Officer | Jun 16, 2015 | Option Exercise | $0.47 | 300 | 140 | 37,570 | Jun 17, 2015, 06:28 PM |
Higgons John Duncan | Chief Operating Officer | Jun 15, 2015 | Sale | $105.23 | 7,000 | 736,610 | 121,835 | Jun 16, 2015, 05:23 PM |
Higgons John Duncan | Chief Operating Officer | Jun 12, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 128,835 | Jun 12, 2015, 04:53 PM |
Higgons John Duncan | Chief Operating Officer | Jun 11, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 118,835 | Jun 12, 2015, 04:53 PM |
Higgons John Duncan | Chief Operating Officer | Jun 10, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 108,835 | Jun 12, 2015, 04:53 PM |
Biller Scott | Chief Scientific Officer | Jun 08, 2015 | Sale | $121.85 | 5,500 | 670,175 | 37,270 | Jun 09, 2015, 05:20 PM |
Schenkein David P | Chief Executive Officer | Jun 01, 2015 | Sale | $120.67 | 13,000 | 1,568,710 | 232,272 | Jun 02, 2015, 06:19 PM |
Bowden Christopher | Chief Medical Officer | Jun 01, 2015 | Option Exercise | $35.16 | 5,000 | 175,800 | 5,000 | Jun 02, 2015, 06:19 PM |
Bowden Christopher | Chief Medical Officer | Jun 01, 2015 | Sale | $120.67 | 5,000 | 603,350 | 0 | Jun 02, 2015, 06:19 PM |
Schenkein David P | Chief Executive Officer | May 27, 2015 | Sale | $120.05 | 8,929 | 1,071,926 | 85,582 | May 28, 2015, 05:34 PM |
Goddard Glenn | Senior Vice President, Finance | May 27, 2015 | Option Exercise | $23.10 | 2,171 | 50,150 | 2,171 | May 28, 2015, 05:30 PM |
Goddard Glenn | Senior Vice President, Finance | May 27, 2015 | Sale | $120.05 | 2,171 | 260,629 | 0 | May 28, 2015, 05:30 PM |
Cantley Lewis Clayton Jr. | Director | May 19, 2015 | Sale | $116.66 | 2,426 | 283,017 | 169,688 | May 21, 2015, 05:12 PM |
Cantley Lewis Clayton Jr. | Director | May 19, 2015 | Sale | $116.69 | 2,426 | 283,090 | 169,688 | May 21, 2015, 05:12 PM |
Cantley Lewis Clayton Jr. | Director | May 20, 2015 | Sale | $116.60 | 2,426 | 282,872 | 167,262 | May 21, 2015, 05:12 PM |
Cantley Lewis Clayton Jr. | Director | May 20, 2015 | Sale | $116.60 | 2,426 | 282,872 | 167,262 | May 21, 2015, 05:12 PM |
Higgons John Duncan | Chief Operating Officer | May 15, 2015 | Sale | $112.89 | 7,417 | 837,305 | 98,835 | May 18, 2015, 07:06 PM |
Schenkein David P | Chief Executive Officer | May 12, 2015 | Sale | $110.03 | 2,093 | 230,293 | 94,701 | May 13, 2015, 04:39 PM |
Schenkein David P | Chief Executive Officer | May 11, 2015 | Sale | $110.01 | 3,107 | 341,801 | 96,794 | May 13, 2015, 04:39 PM |
Schenkein David P | Chief Executive Officer | May 07, 2015 | Option Exercise | $0.30 | 10,000 | 3,025 | 241,372 | May 11, 2015, 05:14 PM |
Schenkein David P | Chief Executive Officer | May 08, 2015 | Sale | $101.32 | 3,900 | 395,148 | 238,772 | May 11, 2015, 05:14 PM |
Schenkein David P | Chief Executive Officer | May 01, 2015 | Sale | $93.63 | 3,900 | 365,157 | 231,372 | May 05, 2015, 04:54 PM |
Cantley Lewis Clayton Jr. | Director | Apr 24, 2015 | Sale | $106.49 | 2,426 | 258,345 | 172,114 | Apr 27, 2015, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Apr 24, 2015 | Sale | $106.45 | 2,426 | 258,248 | 172,114 | Apr 27, 2015, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Apr 23, 2015 | Sale | $103.83 | 2,426 | 251,892 | 174,540 | Apr 27, 2015, 05:43 PM |
Cantley Lewis Clayton Jr. | Director | Apr 23, 2015 | Sale | $103.82 | 2,426 | 251,867 | 174,540 | Apr 27, 2015, 05:43 PM |
Higgons John Duncan | Chief Operating Officer | Apr 15, 2015 | Sale | $99.54 | 6,583 | 655,272 | 106,252 | Apr 17, 2015, 05:26 PM |
Schenkein David P | Chief Executive Officer | Apr 13, 2015 | Sale | $100.03 | 3,900 | 390,117 | 235,272 | Apr 15, 2015, 05:04 PM |
Schenkein David P | Chief Executive Officer | Apr 01, 2015 | Sale | $92.54 | 3,900 | 360,906 | 237,872 | Apr 03, 2015, 05:37 PM |
Cantley Lewis Clayton Jr. | Director | Mar 27, 2015 | Sale | $96.33 | 2,426 | 233,697 | 176,966 | Mar 30, 2015, 05:59 PM |
Cantley Lewis Clayton Jr. | Director | Mar 27, 2015 | Sale | $96.35 | 2,426 | 233,745 | 176,966 | Mar 30, 2015, 05:59 PM |
Cantley Lewis Clayton Jr. | Director | Mar 26, 2015 | Sale | $90.81 | 2,426 | 220,305 | 179,392 | Mar 30, 2015, 05:59 PM |
Cantley Lewis Clayton Jr. | Director | Mar 26, 2015 | Sale | $90.84 | 2,426 | 220,378 | 179,392 | Mar 30, 2015, 05:59 PM |
Higgons John Duncan | Chief Operating Officer | Mar 16, 2015 | Sale | $106.24 | 7,000 | 743,680 | 112,835 | Mar 18, 2015, 05:18 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 16, 2015 | Option Exercise | $27.26 | 10,000 | 272,624 | 10,000 | Mar 18, 2015, 05:17 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 16, 2015 | Sale | $106.24 | 10,000 | 1,062,400 | 0 | Mar 18, 2015, 05:17 PM |
Biller Scott | Chief Scientific Officer | Mar 16, 2015 | Option Exercise | $0.47 | 5,500 | 2,571 | 48,270 | Mar 18, 2015, 05:15 PM |
Biller Scott | Chief Scientific Officer | Mar 16, 2015 | Sale | $106.81 | 5,500 | 587,455 | 42,770 | Mar 18, 2015, 05:15 PM |
Schenkein David P | Chief Executive Officer | Mar 05, 2015 | Sale | $110.16 | 2,600 | 286,416 | 102,501 | Mar 09, 2015, 06:41 PM |
Biller Scott | Chief Scientific Officer | Feb 27, 2015 | Option Exercise | $39.35 | 270 | 10,624 | 42,770 | Mar 03, 2015, 05:22 PM |
Schenkein David P | Chief Executive Officer | Feb 27, 2015 | Option Exercise | $0.30 | 25,000 | 7,563 | 248,272 | Mar 03, 2015, 05:18 PM |
Schenkein David P | Chief Executive Officer | Mar 02, 2015 | Sale | $107.05 | 7,800 | 834,990 | 241,772 | Mar 03, 2015, 05:18 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 13, 2015 | Option Exercise | $23.10 | 1,316 | 30,400 | 1,316 | Feb 17, 2015, 05:20 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 13, 2015 | Sale | $120.31 | 1,316 | 158,328 | 0 | Feb 17, 2015, 05:20 PM |
Schenkein David P | Chief Executive Officer | Feb 13, 2015 | Sale | $120.31 | 684 | 82,292 | 106,401 | Feb 13, 2015, 05:39 PM |
Schenkein David P | Chief Executive Officer | Feb 11, 2015 | Sale | $120.14 | 787 | 94,550 | 107,085 | Feb 13, 2015, 05:39 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 09, 2015 | Option Exercise | $22.08 | 15,000 | 331,237 | 15,000 | Feb 11, 2015, 06:22 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 11, 2015 | Option Exercise | $23.10 | 1,513 | 34,950 | 1,513 | Feb 11, 2015, 06:22 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 11, 2015 | Sale | $120.14 | 1,513 | 181,772 | 0 | Feb 11, 2015, 06:22 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 09, 2015 | Sale | $105.81 | 15,000 | 1,587,150 | 0 | Feb 11, 2015, 06:22 PM |
Schenkein David P | Chief Executive Officer | Feb 02, 2015 | Sale | $114.31 | 10,400 | 1,188,824 | 223,272 | Feb 03, 2015, 06:34 PM |
Biller Scott | Chief Scientific Officer | Jan 02, 2015 | Option Exercise | $0.47 | 4,500 | 2,104 | 47,000 | Jan 06, 2015, 05:36 PM |
Biller Scott | Chief Scientific Officer | Jan 02, 2015 | Sale | $110.08 | 4,500 | 495,360 | 42,500 | Jan 06, 2015, 05:36 PM |
Schenkein David P | Chief Executive Officer | Jan 02, 2015 | Sale | $110.08 | 13,000 | 1,431,040 | 229,772 | Jan 06, 2015, 05:26 PM |
Higgons John Duncan | Chief Operating Officer | Jan 02, 2015 | Sale | $110.08 | 12,000 | 1,320,960 | 119,835 | Jan 06, 2015, 05:23 PM |
Higgons John Duncan | Chief Operating Officer | Jan 02, 2015 | Sale | $110.08 | 12,000 | 1,320,960 | 119,835 | Jan 06, 2015, 05:22 PM |
MARAGANORE JOHN | Director | Dec 16, 2014 | Buy | $110.75 | 1,806 | 200,015 | 50,689 | Dec 18, 2014, 05:42 PM |
Celgene European Investment Co LLC | 10% Owner | Dec 16, 2014 | Buy | $110.75 | 228,645 | 25,322,434 | 1,231,778 | Dec 17, 2014, 04:04 PM |
Schenkein David P | Chief Executive Officer | Dec 01, 2014 | Sale | $97.03 | 13,000 | 1,261,390 | 236,272 | Dec 02, 2014, 06:18 PM |
Higgons John Duncan | Chief Operating Officer | Dec 01, 2014 | Sale | $97.03 | 12,000 | 1,164,360 | 131,835 | Dec 02, 2014, 06:16 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 47,000 | Dec 02, 2014, 06:15 PM |
Biller Scott | Chief Scientific Officer | Dec 01, 2014 | Sale | $97.03 | 4,500 | 436,635 | 42,500 | Dec 02, 2014, 06:15 PM |
Biller Scott | Chief Scientific Officer | Nov 20, 2014 | Option Exercise | $0.47 | 7,500 | 3,506 | 42,500 | Nov 24, 2014, 05:47 PM |
Schenkein David P | Chief Executive Officer | Nov 03, 2014 | Sale | $81.71 | 13,000 | 1,062,230 | 242,772 | Nov 04, 2014, 06:18 PM |
Goddard Glenn | Senior Vice President, Finance | Nov 03, 2014 | Option Exercise | $8.10 | 2,000 | 16,193 | 2,000 | Nov 04, 2014, 06:17 PM |
Goddard Glenn | Senior Vice President, Finance | Nov 03, 2014 | Sale | $81.71 | 2,000 | 163,420 | 0 | Nov 04, 2014, 06:17 PM |
Higgons John Duncan | Chief Operating Officer | Nov 03, 2014 | Sale | $81.71 | 13,000 | 1,062,230 | 143,835 | Nov 04, 2014, 06:16 PM |
Biller Scott | Chief Scientific Officer | Nov 03, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 39,500 | Nov 04, 2014, 06:14 PM |
Biller Scott | Chief Scientific Officer | Nov 03, 2014 | Sale | $81.71 | 4,500 | 367,695 | 35,000 | Nov 04, 2014, 06:14 PM |
Schenkein David P | Chief Executive Officer | Oct 01, 2014 | Option Exercise | $0.30 | 2,500 | 756 | 255,772 | Oct 03, 2014, 05:06 PM |
Schenkein David P | Chief Executive Officer | Oct 01, 2014 | Sale | $60.07 | 13,000 | 780,910 | 249,272 | Oct 03, 2014, 05:06 PM |
Higgons John Duncan | Chief Operating Officer | Oct 01, 2014 | Sale | $60.07 | 13,000 | 780,910 | 156,835 | Oct 03, 2014, 05:05 PM |
Biller Scott | Chief Scientific Officer | Oct 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 39,500 | Oct 03, 2014, 05:04 PM |
Biller Scott | Chief Scientific Officer | Oct 01, 2014 | Sale | $60.07 | 4,500 | 270,315 | 35,000 | Oct 03, 2014, 05:04 PM |
Goddard Glenn | Senior Vice President, Finance | Oct 01, 2014 | Option Exercise | $9.05 | 1,500 | 13,575 | 1,500 | Oct 03, 2014, 05:03 PM |
Goddard Glenn | Senior Vice President, Finance | Oct 01, 2014 | Sale | $60.07 | 1,500 | 90,105 | 0 | Oct 03, 2014, 05:03 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 26, 2014 | Option Exercise | $5.21 | 17,500 | 91,222 | 17,500 | Sep 29, 2014, 05:51 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 26, 2014 | Sale | $56.53 | 17,500 | 989,275 | 0 | Sep 29, 2014, 05:51 PM |
Schenkein David P | Chief Executive Officer | Sep 26, 2014 | Option Exercise | $0.30 | 30,000 | 9,075 | 283,272 | Sep 29, 2014, 05:47 PM |
Schenkein David P | Chief Executive Officer | Sep 26, 2014 | Sale | $62.68 | 60,000 | 3,760,800 | 253,272 | Sep 29, 2014, 05:47 PM |
Biller Scott | Chief Scientific Officer | Sep 19, 2014 | Option Exercise | $0.47 | 37,996 | 17,763 | 72,996 | Sep 22, 2014, 05:49 PM |
Biller Scott | Chief Scientific Officer | Sep 19, 2014 | Sale | $50.45 | 37,996 | 1,916,898 | 35,000 | Sep 22, 2014, 05:49 PM |
Biller Scott | Chief Scientific Officer | Sep 02, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 39,500 | Sep 03, 2014, 06:18 PM |
Biller Scott | Chief Scientific Officer | Aug 07, 2014 | Option Exercise | $0.47 | 5,000 | 2,338 | 35,000 | Sep 03, 2014, 06:18 PM |
Biller Scott | Chief Scientific Officer | Sep 02, 2014 | Sale | $46.30 | 4,500 | 208,350 | 35,000 | Sep 03, 2014, 06:18 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 02, 2014 | Option Exercise | $2.26 | 10,000 | 22,648 | 10,000 | Sep 03, 2014, 06:17 PM |
Goddard Glenn | Senior Vice President, Finance | Sep 02, 2014 | Sale | $46.30 | 10,000 | 463,000 | 0 | Sep 03, 2014, 06:17 PM |
Schenkein David P | Chief Executive Officer | Sep 02, 2014 | Option Exercise | $0.30 | 6,500 | 1,966 | 259,772 | Sep 03, 2014, 06:17 PM |
Schenkein David P | Chief Executive Officer | Sep 02, 2014 | Sale | $46.30 | 13,000 | 601,900 | 253,272 | Sep 03, 2014, 06:17 PM |
Higgons John Duncan | Chief Operating Officer | Sep 02, 2014 | Option Exercise | $0.30 | 6,745 | 2,040 | 182,835 | Sep 03, 2014, 06:16 PM |
Higgons John Duncan | Chief Operating Officer | Sep 02, 2014 | Sale | $46.30 | 13,000 | 601,900 | 169,835 | Sep 03, 2014, 06:16 PM |
Higgons John Duncan | Chief Operating Officer | Aug 26, 2014 | Option Exercise | $0.30 | 5,000 | 1,513 | 181,090 | Aug 28, 2014, 05:00 PM |
Higgons John Duncan | Chief Operating Officer | Aug 26, 2014 | Sale | $45.05 | 5,000 | 225,250 | 176,090 | Aug 28, 2014, 05:00 PM |
Schenkein David P | Chief Executive Officer | Aug 11, 2014 | Sale | $40.17 | 4,530 | 181,970 | 253,272 | Aug 12, 2014, 06:07 PM |
Schenkein David P | Chief Executive Officer | Aug 01, 2014 | Sale | $39.17 | 8,470 | 331,770 | 255,537 | Aug 05, 2014, 07:06 PM |
Higgons John Duncan | Chief Operating Officer | Aug 01, 2014 | Option Exercise | $0.30 | 7,000 | 2,118 | 183,090 | Aug 05, 2014, 07:03 PM |
Higgons John Duncan | Chief Operating Officer | Aug 01, 2014 | Sale | $39.09 | 7,000 | 273,630 | 176,090 | Aug 05, 2014, 07:03 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 34,500 | Aug 05, 2014, 07:01 PM |
Biller Scott | Chief Scientific Officer | Aug 01, 2014 | Sale | $39.09 | 4,500 | 175,905 | 30,000 | Aug 05, 2014, 07:01 PM |
Schenkein David P | Chief Executive Officer | Jul 01, 2014 | Sale | $46.52 | 13,000 | 604,760 | 259,772 | Jul 02, 2014, 07:12 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 01, 2014 | Option Exercise | $1.11 | 3,500 | 3,893 | 3,500 | Jul 02, 2014, 07:07 PM |
Goddard Glenn | Senior Vice President, Finance | Jul 01, 2014 | Sale | $46.52 | 3,500 | 162,820 | 0 | Jul 02, 2014, 07:07 PM |
Higgons John Duncan | Chief Operating Officer | Jul 01, 2014 | Sale | $46.52 | 12,000 | 558,240 | 176,090 | Jul 02, 2014, 07:06 PM |
Biller Scott | Chief Scientific Officer | Jul 01, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 34,500 | Jul 02, 2014, 07:05 PM |
Biller Scott | Chief Scientific Officer | Jul 01, 2014 | Sale | $46.52 | 4,500 | 209,340 | 30,000 | Jul 02, 2014, 07:05 PM |
MARAGANORE JOHN | Director | Jun 23, 2014 | Buy | $43.98 | 2,300 | 101,154 | 48,883 | Jun 24, 2014, 08:20 AM |
Biller Scott | Chief Scientific Officer | Jun 20, 2014 | Option Exercise | $0.47 | 2,004 | 937 | 32,004 | Jun 23, 2014, 05:40 PM |
Biller Scott | Chief Scientific Officer | Jun 20, 2014 | Sale | $50.05 | 2,004 | 100,300 | 30,000 | Jun 23, 2014, 05:40 PM |
Higgons John Duncan | Chief Operating Officer | Jun 13, 2014 | Sale | $45.27 | 5,000 | 226,350 | 188,090 | Jun 16, 2014, 06:01 PM |
Higgons John Duncan | Chief Operating Officer | Jun 03, 2014 | Sale | $35.01 | 3,700 | 129,537 | 193,090 | Jun 04, 2014, 06:44 PM |
Higgons John Duncan | Chief Operating Officer | Jun 02, 2014 | Sale | $33.87 | 3,300 | 111,771 | 196,790 | Jun 04, 2014, 06:44 PM |
Biller Scott | Chief Scientific Officer | Jun 02, 2014 | Option Exercise | $0.47 | 4,500 | 2,104 | 34,500 | Jun 04, 2014, 06:39 PM |
Biller Scott | Chief Scientific Officer | Jun 02, 2014 | Sale | $33.76 | 4,500 | 151,920 | 30,000 | Jun 04, 2014, 06:39 PM |
Higgons John Duncan | Chief Operating Officer | May 06, 2014 | Sale | $45.73 | 5,000 | 228,650 | 200,090 | May 07, 2014, 06:33 PM |
Goddard Glenn | Senior Vice President, Finance | May 01, 2014 | Option Exercise | $1.27 | 2,000 | 2,532 | 2,000 | May 05, 2014, 05:17 PM |
Goddard Glenn | Senior Vice President, Finance | May 01, 2014 | Sale | $42.39 | 2,000 | 84,780 | 0 | May 05, 2014, 05:17 PM |
Higgons John Duncan | Chief Operating Officer | May 01, 2014 | Option Exercise | $0.30 | 3,000 | 908 | 212,090 | May 05, 2014, 05:16 PM |
Higgons John Duncan | Chief Operating Officer | May 01, 2014 | Sale | $42.39 | 7,000 | 296,730 | 205,090 | May 05, 2014, 05:16 PM |
Biller Scott | Chief Scientific Officer | May 01, 2014 | Option Exercise | $0.47 | 13,500 | 6,311 | 34,500 | May 05, 2014, 05:16 PM |
Biller Scott | Chief Scientific Officer | May 01, 2014 | Sale | $42.39 | 13,500 | 572,265 | 30,000 | May 05, 2014, 05:16 PM |
MARAGANORE JOHN | Director | Apr 29, 2014 | Buy | $44.00 | 2,250 | 99,000 | 46,583 | Apr 30, 2014, 06:11 PM |
Celgene European Investment Co LLC | 10% Owner | Apr 29, 2014 | Buy | $44.00 | 294,800 | 12,971,200 | 1,003,133 | Apr 30, 2014, 04:01 PM |
Higgons John Duncan | Chief Operating Officer | Apr 07, 2014 | Option Exercise | $0.30 | 3,000 | 908 | 212,090 | Apr 08, 2014, 07:35 PM |
Higgons John Duncan | Chief Operating Officer | Apr 07, 2014 | Sale | $45.17 | 3,000 | 135,510 | 209,090 | Apr 08, 2014, 07:35 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 07, 2014 | Option Exercise | $1.16 | 2,000 | 2,315 | 2,000 | Apr 08, 2014, 07:32 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 07, 2014 | Sale | $45.17 | 2,000 | 90,340 | 0 | Apr 08, 2014, 07:32 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 01, 2014 | Option Exercise | $0.64 | 4,000 | 2,542 | 4,000 | Apr 03, 2014, 05:47 PM |
Goddard Glenn | Senior Vice President, Finance | Apr 01, 2014 | Sale | $38.08 | 4,000 | 152,320 | 0 | Apr 03, 2014, 05:47 PM |
Higgons John Duncan | Chief Operating Officer | Apr 01, 2014 | Option Exercise | $0.30 | 12,000 | 3,630 | 221,090 | Apr 03, 2014, 05:46 PM |
Higgons John Duncan | Chief Operating Officer | Apr 01, 2014 | Sale | $38.08 | 12,000 | 456,960 | 209,090 | Apr 03, 2014, 05:46 PM |
Biller Scott | Chief Scientific Officer | Apr 01, 2014 | Option Exercise | $0.47 | 34,500 | 16,129 | 34,500 | Apr 03, 2014, 05:44 PM |
Biller Scott | Chief Scientific Officer | Apr 01, 2014 | Sale | $38.08 | 4,500 | 171,360 | 30,000 | Apr 03, 2014, 05:44 PM |
Tessier-Lavigne Marc | Director | Jul 24, 2013 | Buy | $18.00 | 55,555 | 999,990 | 101,009 | Apr 03, 2014, 05:43 PM |
MARAGANORE JOHN | Director | Jul 24, 2013 | Buy | $18.00 | 8,333 | 149,994 | 44,333 | Apr 03, 2014, 05:41 PM |
Schenkein David P | Chief Executive Officer | Mar 25, 2014 | Option Exercise | $0.30 | 25,000 | 7,563 | 266,272 | Mar 27, 2014, 06:09 PM |
Higgons John Duncan | Chief Operating Officer | Mar 19, 2014 | Option Exercise | $0.30 | 80,000 | 24,200 | 209,090 | Mar 20, 2014, 06:06 PM |
Schenkein David P | Chief Executive Officer | Mar 10, 2014 | Option Exercise | $0.30 | 54,000 | 16,335 | 241,272 | Mar 12, 2014, 06:19 PM |
Higgons John Duncan | Chief Operating Officer | Mar 10, 2014 | Option Exercise | $0.30 | 20,000 | 6,050 | 129,090 | Mar 12, 2014, 06:16 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 07, 2014 | Option Exercise | $0.51 | 12,000 | 6,123 | 12,000 | Mar 07, 2014, 06:20 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 06, 2014 | Option Exercise | $0.47 | 5,468 | 2,556 | 5,468 | Mar 07, 2014, 06:20 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 07, 2014 | Sale | $45.10 | 12,000 | 541,200 | 0 | Mar 07, 2014, 06:20 PM |
Goddard Glenn | Senior Vice President, Finance | Mar 06, 2014 | Sale | $35.54 | 5,468 | 194,333 | 0 | Mar 07, 2014, 06:20 PM |
Higgons John Duncan | Chief Operating Officer | Mar 07, 2014 | Option Exercise | $0.30 | 9,000 | 2,723 | 118,090 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 06, 2014 | Option Exercise | $0.30 | 5,646 | 1,708 | 114,736 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 06, 2014 | Sale | $35.54 | 5,646 | 200,659 | 109,090 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 07, 2014 | Sale | $45.10 | 9,000 | 405,900 | 109,090 | Mar 07, 2014, 05:53 PM |
Higgons John Duncan | Chief Operating Officer | Mar 03, 2014 | Option Exercise | $0.30 | 8,000 | 2,420 | 117,090 | Mar 04, 2014, 05:42 PM |
Higgons John Duncan | Chief Operating Officer | Mar 03, 2014 | Sale | $29.85 | 8,000 | 238,832 | 109,090 | Mar 04, 2014, 05:42 PM |
Biller Scott | Chief Scientific Officer | Mar 03, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Mar 04, 2014, 05:40 PM |
Biller Scott | Chief Scientific Officer | Mar 03, 2014 | Sale | $29.85 | 6,000 | 179,124 | 0 | Mar 04, 2014, 05:40 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 18, 2014 | Option Exercise | $0.47 | 3,532 | 1,651 | 3,532 | Feb 20, 2014, 06:46 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 18, 2014 | Sale | $35.06 | 3,532 | 123,832 | 0 | Feb 20, 2014, 06:46 PM |
Higgons John Duncan | Chief Operating Officer | Feb 18, 2014 | Option Exercise | $0.30 | 2,354 | 712 | 111,444 | Feb 20, 2014, 05:58 PM |
Higgons John Duncan | Chief Operating Officer | Feb 18, 2014 | Sale | $35.06 | 2,354 | 82,531 | 109,090 | Feb 20, 2014, 05:58 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 10, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Feb 11, 2014, 06:09 PM |
Goddard Glenn | Senior Vice President, Finance | Feb 10, 2014 | Sale | $30.44 | 6,000 | 182,640 | 0 | Feb 11, 2014, 06:09 PM |
Higgons John Duncan | Chief Operating Officer | Feb 03, 2014 | Option Exercise | $0.30 | 8,000 | 2,420 | 117,090 | Feb 04, 2014, 08:56 PM |
Higgons John Duncan | Chief Operating Officer | Feb 03, 2014 | Sale | $25.97 | 8,000 | 207,728 | 109,090 | Feb 04, 2014, 08:56 PM |
Biller Scott | Chief Scientific Officer | Feb 03, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Feb 04, 2014, 08:54 PM |
Biller Scott | Chief Scientific Officer | Feb 03, 2014 | Sale | $25.97 | 6,000 | 155,796 | 0 | Feb 04, 2014, 08:54 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 27, 2014 | Option Exercise | $0.47 | 7,000 | 3,273 | 7,000 | Jan 28, 2014, 05:07 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 27, 2014 | Sale | $26.29 | 7,000 | 184,051 | 0 | Jan 28, 2014, 05:07 PM |
Biller Scott | Chief Scientific Officer | Jan 21, 2014 | Option Exercise | $0.47 | 6,000 | 2,805 | 6,000 | Jan 23, 2014, 06:04 PM |
Biller Scott | Chief Scientific Officer | Jan 21, 2014 | Sale | $34.71 | 6,000 | 208,265 | 0 | Jan 23, 2014, 06:04 PM |
Higgons John Duncan | Chief Operating Officer | Jan 21, 2014 | Option Exercise | $0.30 | 12,000 | 3,630 | 121,090 | Jan 23, 2014, 06:02 PM |
Higgons John Duncan | Chief Operating Officer | Jan 21, 2014 | Sale | $34.71 | 12,000 | 416,530 | 109,090 | Jan 23, 2014, 06:02 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 21, 2014 | Option Exercise | $0.47 | 10,000 | 4,675 | 10,000 | Jan 22, 2014, 06:30 PM |
Goddard Glenn | Senior Vice President, Finance | Jan 21, 2014 | Sale | $34.71 | 10,000 | 347,108 | 0 | Jan 22, 2014, 06:30 PM |
Celgene European Investment Co LLC | 10% Owner | Jul 29, 2013 | Buy | $18.00 | 708,333 | 12,749,994 | 708,333 | Jul 30, 2013, 11:58 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
FOUSE JACQUALYN A | Director | 04/10/2024 | 214,642 |
Foster-Cheek Kaye I | Director | 03/07/2024 | 40,632 |
Foster-Cheek Kaye I | Director | 03/06/2024 | 141,236 |
Foster-Cheek Kaye I | Director | 03/05/2024 | 9,663 |
Washburn Theodore James Jr. | Principal Accounting Officer | 03/05/2024 | 60,738 |
Burns James William | Chief Legal Officer | 03/05/2024 | 86,050 |
Schenkein David P | Director | 02/27/2024 | 2,193,570 |
Schenkein David P | Director | 02/27/2024 | 2,403,592 |
Schenkein David P | Director | 02/26/2024 | 645,804 |
Schenkein David P | Director | 02/23/2024 | 1,510,209 |
Schenkein David P | Director | 02/26/2024 | 677,441 |
Schenkein David P | Director | 02/23/2024 | 1,577,510 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/20/2024 | 13,422 |
Gheuens Sarah | Chief Medical Officer | 02/14/2024 | 16,140 |
Burns James William | Chief Legal Officer | 02/14/2024 | 13,701 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2024 | 6,863 |
Burns James William | Chief Legal Officer | 01/24/2024 | 36,961 |
Gheuens Sarah | Chief Medical Officer | 01/24/2024 | 36,961 |
Jones Cecilia | Chief Financial Officer | 01/24/2024 | 40,813 |
FOUSE JACQUALYN A | Director | 01/24/2024 | 232,024 |
Goff Brian | Chief Executive Officer | 01/24/2024 | 165,221 |
Milanova Tsveta | Chief Commercial Officer | 01/24/2024 | 35,014 |
Goff Brian | Chief Executive Officer | 01/09/2024 | 277,397 |
FOUSE JACQUALYN A | Director | 01/09/2024 | 192,909 |
Burns James William | Chief Legal Officer | 01/09/2024 | 26,737 |
Gheuens Sarah | Chief Medical Officer | 01/09/2024 | 41,129 |
Milanova Tsveta | Chief Commercial Officer | 01/05/2024 | 64,773 |
Jones Cecilia | Chief Financial Officer | 09/28/2023 | 54,017 |
Burns James William | Chief Legal Officer | 08/17/2023 | 168,061 |
Foster-Cheek Kaye I | Director | 08/09/2023 | 452,250 |
Foster-Cheek Kaye I | Director | 08/09/2023 | 648,887 |
Goff Brian | Chief Executive Officer | 08/08/2023 | 259,335 |
Washburn Theodore James Jr. | Principal Accounting Officer | 08/07/2023 | 74,096 |
Washburn Theodore James Jr. | Principal Accounting Officer | 08/01/2023 | 32,352 |
Burns James William | Chief Legal Officer | 06/30/2023 | 48,411 |
FOUSE JACQUALYN A | Director | 06/30/2023 | 303,962 |
Gheuens Sarah | Chief Medical Officer | 06/30/2023 | 48,411 |
Goff Brian | Chief Executive Officer | 06/30/2023 | 324,694 |
Jones Cecilia | Chief Financial Officer | 06/30/2023 | 45,291 |
Milanova Tsveta | Chief Commercial Officer | 06/30/2023 | 45,886 |
FOUSE JACQUALYN A | Director | 04/12/2023 | 101,007 |
Schenkein David P | Director | 04/03/2023 | 148,085 |
Schenkein David P | Director | 04/03/2023 | 373,895 |
Schenkein David P | Director | 03/27/2023 | 181,000 |
Schenkein David P | Director | 03/27/2023 | 443,000 |
Schenkein David P | Director | 03/13/2023 | 181,000 |
Schenkein David P | Director | 03/13/2023 | 449,817 |
Washburn Theodore James Jr. | Principal Accounting Officer | 03/03/2023 | 12,242 |
Gheuens Sarah | Chief Medical Officer | 03/03/2023 | 28,373 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2023 | 3,672 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2023 | 14,409 |
Burns James William | Chief Legal Officer | 02/16/2023 | 17,606 |
FOUSE JACQUALYN A | Director | 02/16/2023 | 105,464 |
Schenkein David P | Director | 02/13/2023 | 181,000 |
Schenkein David P | Director | 02/13/2023 | 572,400 |
Burns James William | Chief Legal Officer | 02/14/2023 | 18,287 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2023 | 7,764 |
Schenkein David P | Director | 01/30/2023 | 181,000 |
Schenkein David P | Director | 01/30/2023 | 586,578 |
Schenkein David P | Director | 01/17/2023 | 181,000 |
Schenkein David P | Director | 01/17/2023 | 577,093 |
Burns James William | Chief Legal Officer | 12/28/2022 | 73,963 |
Gheuens Sarah | Chief Medical Officer | 12/28/2022 | 79,260 |
Gheuens Sarah | Chief Medical Officer | 12/06/2022 | 7,150 |
Poddar Richa | Chief Commercial Officer | 10/17/2022 | 40,808 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/25/2022 | 3,240 |
Gheuens Sarah | Chief Medical Officer | 02/22/2022 | 27,771 |
Poddar Richa | Chief Commercial Officer | 02/22/2022 | 21,577 |
Car Bruce | Chief Scientific Officer | 02/22/2022 | 59,352 |
Biller Jonathan | Chief Financial Officer | 02/22/2022 | 78,167 |
FOUSE JACQUALYN A | Chief Executive Officer | 02/22/2022 | 106,840 |
Burns James William | Chief Legal Officer | 02/22/2022 | 6,252 |
Schenkein David P | Director | 02/22/2022 | 22,043 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/22/2022 | 1,716 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/16/2022 | 7,179 |
FOUSE JACQUALYN A | Chief Executive Officer | 02/14/2022 | 106,903 |
Burns James William | Chief Legal Officer | 02/14/2022 | 65,728 |
Poddar Richa | Chief Commercial Officer | 02/14/2022 | 17,995 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2022 | 3,874 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/14/2022 | 15,750 |
Gheuens Sarah | Chief Medical Officer | 02/10/2022 | 23,820 |
Washburn Theodore James Jr. | Principal Accounting Officer | 02/10/2022 | 8,579 |
Biller Jonathan | Chief Financial Officer | 02/10/2022 | 42,392 |
Burns James William | Chief Legal Officer | 02/10/2022 | 20,206 |
Poddar Richa | Chief Commercial Officer | 02/10/2022 | 22,783 |
Car Bruce | Chief Scientific Officer | 01/06/2022 | 39,259 |
Gheuens Sarah | Chief Medical Officer | 12/02/2021 | 8,680 |
Biller Jonathan | Chief Financial Officer | 12/03/2021 | 65,406 |
Alenson Carman | Principal Accounting Officer | 06/21/2021 | 91,533 |
Alenson Carman | Principal Accounting Officer | 06/21/2021 | 109,481 |
Bowden Christopher | Chief Medical Officer | 06/18/2021 | 2,423,991 |
Bowden Christopher | Chief Medical Officer | 06/18/2021 | 2,914,851 |
Miles Darrin | Chief Commercial Officer | 05/14/2021 | 191,829 |
Bowden Christopher | Chief Medical Officer | 04/20/2021 | 515,024 |
Bowden Christopher | Chief Medical Officer | 04/19/2021 | 112,864 |
Bowden Christopher | Chief Medical Officer | 04/20/2021 | 793,581 |
Bowden Christopher | Chief Medical Officer | 04/19/2021 | 177,055 |
Miles Darrin | Chief Commercial Officer | 03/05/2021 | 24,290 |
Miles Darrin | Chief Commercial Officer | 03/01/2021 | 105,578 |
Biller Jonathan | Chief Financial Officer | 12/03/2020 | 78,300 |
Alenson Carman | Principal Accounting Officer | 09/02/2020 | 9,983 |
Bowden Christopher | Chief Medical Officer | 05/20/2020 | 125,978 |
Bowden Christopher | Chief Medical Officer | 05/20/2020 | 179,200 |
Hirsch Andrew | Chief Financial Officer | 04/22/2020 | 88,469 |
Biller Jonathan | Chief Legal Officer | 04/14/2020 | 102,779 |
Hirsch Andrew | Chief Financial Officer | 04/14/2020 | 64,983 |
FOUSE JACQUALYN A | Chief Executive Officer | 04/14/2020 | 149,271 |
Car Bruce | Chief Scientific Officer | 04/14/2020 | 82,377 |
Bowden Christopher | Chief Medical Officer | 04/14/2020 | 96,236 |
Alenson Carman | Principal Accounting Officer | 03/02/2020 | 16,318 |
Alenson Carman | Principal Accounting Officer | 02/26/2020 | 22,241 |
Hirsch Andrew | Chief Financial Officer | 02/24/2020 | 51,385 |
Bowden Christopher | Chief Medical Officer | 02/24/2020 | 77,661 |
Schenkein David P | Director | 02/24/2020 | 42,821 |
Alenson Carman | Principal Accounting Officer | 02/24/2020 | 10,657 |
Alenson Carman | Principal Accounting Officer | 02/20/2020 | 129,529 |
Alenson Carman | Principal Accounting Officer | 02/18/2020 | 60,488 |
Bowden Christopher | Chief Medical Officer | 02/18/2020 | 42,596 |
Hirsch Andrew | Chief Financial Officer | 02/18/2020 | 46,081 |
Schenkein David P | Director | 02/18/2020 | 131,793 |
Bowden Christopher | Chief Medical Officer | 02/11/2020 | 21,834 |
Bowden Christopher | Chief Medical Officer | 02/11/2020 | 31,063 |
Bowden Christopher | Chief Medical Officer | 02/05/2020 | 1,246,317 |
Bowden Christopher | Chief Medical Officer | 02/04/2020 | 299,774 |
Bowden Christopher | Chief Medical Officer | 02/04/2020 | 2,485,989 |
Alenson Carman | Principal Accounting Officer | 12/26/2019 | 147,766 |
FOUSE JACQUALYN A | Chief Executive Officer | 11/13/2019 | 1,249,982 |
Schenkein David P | Director | 11/13/2019 | 249,984 |
CELGENE CORP /DE/ | 10% Owner | 11/12/2019 | 12,499,975 |
Biller Scott | Chief Scientific Officer | 06/11/2019 | 16,872 |
Biller Scott | Chief Scientific Officer | 04/05/2019 | 119,280 |
Biller Scott | Chief Scientific Officer | 04/05/2019 | 203,135 |
Bowden Christopher | Chief Medical Officer | 04/01/2019 | 351,600 |
Bowden Christopher | Chief Medical Officer | 04/01/2019 | 665,747 |
Bowden Christopher | Chief Medical Officer | 03/15/2019 | 351,600 |
Bowden Christopher | Chief Medical Officer | 03/15/2019 | 641,615 |
Biller Scott | Chief Scientific Officer | 03/05/2019 | 115,805 |
Biller Scott | Chief Scientific Officer | 03/05/2019 | 203,032 |
Hoerter Steven L. | Chief Commercial Officer | 03/01/2019 | 198,800 |
Hoerter Steven L. | Chief Commercial Officer | 03/04/2019 | 198,800 |
Hoerter Steven L. | Chief Commercial Officer | 03/04/2019 | 340,000 |
Hoerter Steven L. | Chief Commercial Officer | 03/01/2019 | 330,050 |
Biller Scott | Chief Scientific Officer | 02/27/2019 | 135,875 |
Biller Scott | Chief Scientific Officer | 02/27/2019 | 585,000 |
Alenson Carman | Principal Accounting Officer | 02/21/2019 | 57,231 |
Schenkein David P | Director | 02/19/2019 | 143,392 |
Hoerter Steven L. | Chief Commercial Officer | 02/19/2019 | 60,351 |
Hirsch Andrew | Chief Financial Officer | 02/19/2019 | 47,643 |
Bowden Christopher | Chief Medical Officer | 02/19/2019 | 47,469 |
Biller Scott | Chief Scientific Officer | 02/19/2019 | 50,834 |
Alenson Carman | Principal Accounting Officer | 02/19/2019 | 16,132 |
Alenson Carman | Principal Accounting Officer | 09/28/2018 | 11,620 |
Hirsch Andrew | Chief Financial Officer | 01/22/2019 | 240,595 |
Hoerter Steven L. | Chief Commercial Officer | 01/22/2019 | 304,719 |
Bowden Christopher | Chief Medical Officer | 01/22/2019 | 103,527 |
Biller Scott | Chief Scientific Officer | 12/21/2018 | 47,919 |
Biller Scott | Chief Scientific Officer | 11/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 11/05/2018 | 209,071 |
Biller Scott | Chief Scientific Officer | 10/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 10/05/2018 | 209,377 |
MARAGANORE JOHN | Director | 09/11/2018 | 986,129 |
MARAGANORE JOHN | Director | 09/12/2018 | 1,015,982 |
Schenkein David P | Chief Executive Officer | 09/10/2018 | 276,217 |
Schenkein David P | Chief Executive Officer | 09/05/2018 | 249,028 |
Alenson Carman | Principal Accounting Officer | 09/05/2018 | 16,314 |
Alenson Carman | Principal Accounting Officer | 09/05/2018 | 25,896 |
Biller Scott | Chief Scientific Officer | 09/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 09/05/2018 | 249,215 |
Bowden Christopher | Chief Medical Officer | 08/30/2018 | 59,772 |
Bowden Christopher | Chief Medical Officer | 08/29/2018 | 10,548 |
Bowden Christopher | Chief Medical Officer | 08/30/2018 | 136,051 |
Bowden Christopher | Chief Medical Officer | 08/29/2018 | 24,000 |
Hoerter Steven L. | Chief Commercial Officer | 08/24/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 08/24/2018 | 153,586 |
Biller Scott | Chief Scientific Officer | 08/06/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 08/06/2018 | 240,333 |
Hoerter Steven L. | Chief Commercial Officer | 07/25/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 07/25/2018 | 173,389 |
Bowden Christopher | Chief Medical Officer | 07/10/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 07/10/2018 | 173,512 |
Alenson Carman | Principal Accounting Officer | 07/09/2018 | 14,223 |
Alenson Carman | Principal Accounting Officer | 07/09/2018 | 23,104 |
Biller Scott | Chief Scientific Officer | 07/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 07/05/2018 | 250,503 |
Hoerter Steven L. | Chief Commercial Officer | 06/22/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 06/22/2018 | 200,039 |
Foster-Cheek Kaye I | Director | 06/14/2018 | 456,570 |
Foster-Cheek Kaye I | Director | 06/14/2018 | 841,926 |
Bowden Christopher | Chief Medical Officer | 06/12/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 06/12/2018 | 185,786 |
Biller Scott | Chief Scientific Officer | 06/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 06/05/2018 | 280,101 |
Schenkein David P | Chief Executive Officer | 06/01/2018 | 6,280 |
Schenkein David P | Chief Executive Officer | 06/01/2018 | 1,239,608 |
Schenkein David P | Chief Executive Officer | 05/30/2018 | 17,675 |
Schenkein David P | Chief Executive Officer | 05/30/2018 | 4,109,534 |
Schenkein David P | Chief Executive Officer | 05/23/2018 | 14,936 |
Schenkein David P | Chief Executive Officer | 05/23/2018 | 4,463,524 |
Hoerter Steven L. | Chief Commercial Officer | 05/23/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 05/23/2018 | 175,808 |
Biller Scott | Chief Scientific Officer | 05/23/2018 | 480,200 |
Biller Scott | Chief Scientific Officer | 05/23/2018 | 1,365,930 |
Bowden Christopher | Chief Medical Officer | 05/11/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 05/11/2018 | 170,003 |
Bowden Christopher | Chief Medical Officer | 05/08/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 05/08/2018 | 162,760 |
Biller Scott | Chief Scientific Officer | 05/07/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 05/07/2018 | 245,430 |
Schenkein David P | Chief Executive Officer | 05/01/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 05/01/2018 | 1,079,500 |
Hoerter Steven L. | Chief Commercial Officer | 04/23/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 04/23/2018 | 176,197 |
Bowden Christopher | Chief Medical Officer | 04/12/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 04/12/2018 | 170,190 |
Biller Scott | Chief Scientific Officer | 04/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 04/05/2018 | 225,607 |
Schenkein David P | Chief Executive Officer | 04/02/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 04/02/2018 | 1,010,357 |
Biller Scott | Chief Scientific Officer | 03/28/2018 | 9,611 |
Hoerter Steven L. | Chief Commercial Officer | 03/22/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 03/22/2018 | 173,533 |
Foster-Cheek Kaye I | Director | 03/19/2018 | 321,844 |
Foster-Cheek Kaye I | Director | 03/19/2018 | 557,396 |
Scadden David | Director | 03/16/2018 | 16,688 |
Bowden Christopher | Chief Medical Officer | 03/14/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 03/14/2018 | 164,661 |
Biller Scott | Chief Scientific Officer | 03/05/2018 | 27,150 |
Biller Scott | Chief Scientific Officer | 03/05/2018 | 249,229 |
Schenkein David P | Chief Executive Officer | 03/01/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 03/01/2018 | 1,054,218 |
Foster-Cheek Kaye I | Director | 02/26/2018 | 104,126 |
Hoerter Steven L. | Chief Commercial Officer | 02/22/2018 | 81,508 |
Hoerter Steven L. | Chief Commercial Officer | 02/22/2018 | 161,191 |
Bowden Christopher | Chief Medical Officer | 02/16/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 02/16/2018 | 155,305 |
Biller Scott | Chief Scientific Officer | 02/05/2018 | 26,601 |
Biller Scott | Chief Scientific Officer | 02/05/2018 | 228,128 |
Bowden Christopher | Chief Medical Officer | 02/01/2018 | 70,320 |
Bowden Christopher | Chief Medical Officer | 02/01/2018 | 157,500 |
Schenkein David P | Chief Executive Officer | 02/01/2018 | 3,933 |
Schenkein David P | Chief Executive Officer | 02/01/2018 | 1,023,756 |
CELGENE CORP /DE/ | 10% Owner | 01/23/2018 | 57,027,318 |
Schenkein David P | Chief Executive Officer | 01/26/2018 | 7,131 |
Schenkein David P | Chief Executive Officer | 01/26/2018 | 1,911,494 |
Alenson Carman | Principal Accounting Officer | 01/12/2018 | 112,424 |
Alenson Carman | Principal Accounting Officer | 01/12/2018 | 161,250 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 6 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 1,600 |
Hoerter Steven L. | Chief Commercial Officer | 01/23/2018 | 994,000 |
Hoerter Steven L. | Chief Commercial Officer | 01/23/2018 | 1,870,750 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 4,094 |
Schenkein David P | Chief Executive Officer | 01/23/2018 | 9,945 |
Schenkein David P | Chief Executive Officer | 01/24/2018 | 1,082,775 |
Schenkein David P | Chief Executive Officer | 01/23/2018 | 2,630,329 |
CELGENE CORP /DE/ | 10% Owner | 01/23/2018 | 57,027,318 |
Schenkein David P | Chief Executive Officer | 01/16/2018 | 16,033 |
Schenkein David P | Chief Executive Officer | 01/16/2018 | 3,877,218 |
Biller Scott | Chief Scientific Officer | 01/10/2018 | 1,403 |
Biller Scott | Chief Scientific Officer | 01/10/2018 | 195,000 |
Cantley Lewis Clayton Jr. | Director | 12/07/2017 | 55,332 |
Cantley Lewis Clayton Jr. | Director | 12/07/2017 | 55,332 |
Cantley Lewis Clayton Jr. | Director | 12/06/2017 | 58,597 |
Cantley Lewis Clayton Jr. | Director | 12/06/2017 | 58,596 |
Biller Scott | Chief Scientific Officer | 12/06/2017 | 81,376 |
Schenkein David P | Chief Executive Officer | 12/01/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 12/01/2017 | 369,288 |
Biller Scott | Chief Scientific Officer | 12/01/2017 | 67,899 |
Biller Scott | Chief Scientific Officer | 12/01/2017 | 130,459 |
Cantley Lewis Clayton Jr. | Director | 11/13/2017 | 62,070 |
Cantley Lewis Clayton Jr. | Director | 11/14/2017 | 59,700 |
Cantley Lewis Clayton Jr. | Director | 11/14/2017 | 59,700 |
Cantley Lewis Clayton Jr. | Director | 11/13/2017 | 62,070 |
Biller Scott | Chief Scientific Officer | 11/01/2017 | 67,899 |
Biller Scott | Chief Scientific Officer | 11/01/2017 | 134,522 |
Schenkein David P | Chief Executive Officer | 11/01/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 11/01/2017 | 383,105 |
Cantley Lewis Clayton Jr. | Director | 10/16/2017 | 71,090 |
Cantley Lewis Clayton Jr. | Director | 10/16/2017 | 71,090 |
Cantley Lewis Clayton Jr. | Director | 10/17/2017 | 71,100 |
Cantley Lewis Clayton Jr. | Director | 10/17/2017 | 71,100 |
Biller Scott | Chief Scientific Officer | 10/04/2017 | 732,900 |
Schenkein David P | Chief Executive Officer | 10/04/2017 | 24,200 |
Schenkein David P | Chief Executive Officer | 10/04/2017 | 5,611,200 |
Biller Scott | Chief Scientific Officer | 10/02/2017 | 40,995 |
Biller Scott | Chief Scientific Officer | 10/02/2017 | 144,276 |
Schenkein David P | Chief Executive Officer | 10/02/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 10/02/2017 | 400,560 |
Schenkein David P | Chief Executive Officer | 09/18/2017 | 10,588 |
Schenkein David P | Chief Executive Officer | 09/18/2017 | 2,349,200 |
Cantley Lewis Clayton Jr. | Director | 09/13/2017 | 65,470 |
Cantley Lewis Clayton Jr. | Director | 09/13/2017 | 65,470 |
Cantley Lewis Clayton Jr. | Director | 09/14/2017 | 65,710 |
Cantley Lewis Clayton Jr. | Director | 09/14/2017 | 65,710 |
Bowden Christopher | Chief Medical Officer | 09/11/2017 | 210,960 |
Bowden Christopher | Chief Medical Officer | 09/11/2017 | 390,000 |
Biller Scott | Chief Scientific Officer | 09/11/2017 | 975,000 |
Biller Scott | Chief Scientific Officer | 09/01/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 09/01/2017 | 133,031 |
Schenkein David P | Chief Executive Officer | 09/01/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 09/01/2017 | 373,200 |
Cantley Lewis Clayton Jr. | Director | 08/23/2017 | 57,080 |
Cantley Lewis Clayton Jr. | Director | 08/23/2017 | 57,080 |
Cantley Lewis Clayton Jr. | Director | 08/22/2017 | 56,620 |
Cantley Lewis Clayton Jr. | Director | 08/22/2017 | 56,620 |
Biller Scott | Chief Scientific Officer | 08/01/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 08/02/2017 | 1,261,260 |
Biller Scott | Chief Scientific Officer | 08/01/2017 | 118,137 |
Schenkein David P | Chief Executive Officer | 08/01/2017 | 908 |
Schenkein David P | Chief Executive Officer | 08/02/2017 | 7,260 |
Schenkein David P | Chief Executive Officer | 08/02/2017 | 1,453,200 |
Schenkein David P | Chief Executive Officer | 08/01/2017 | 165,360 |
Cantley Lewis Clayton Jr. | Director | 07/20/2017 | 57,125 |
Cantley Lewis Clayton Jr. | Director | 07/20/2017 | 57,125 |
Cantley Lewis Clayton Jr. | Director | 07/19/2017 | 196,505 |
Cantley Lewis Clayton Jr. | Director | 07/19/2017 | 196,505 |
Biller Scott | Chief Scientific Officer | 07/07/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 07/07/2017 | 118,030 |
Schenkein David P | Chief Executive Officer | 07/03/2017 | 908 |
Schenkein David P | Chief Executive Officer | 07/03/2017 | 153,540 |
Biller Scott | Chief Scientific Officer | 06/23/2017 | 1,403 |
Biller Scott | Chief Scientific Officer | 06/21/2017 | 40,245 |
Biller Scott | Chief Scientific Officer | 06/21/2017 | 236,060 |
Cantley Lewis Clayton Jr. | Director | 06/14/2017 | 25,545 |
Cantley Lewis Clayton Jr. | Director | 06/13/2017 | 25,320 |
Cantley Lewis Clayton Jr. | Director | 06/13/2017 | 25,320 |
Cantley Lewis Clayton Jr. | Director | 06/14/2017 | 25,545 |
Schenkein David P | Chief Executive Officer | 06/06/2017 | 333 |
Schenkein David P | Chief Executive Officer | 06/07/2017 | 575 |
Schenkein David P | Chief Executive Officer | 06/07/2017 | 95,038 |
Schenkein David P | Chief Executive Officer | 06/06/2017 | 55,022 |
Cantley Lewis Clayton Jr. | Director | 05/25/2017 | 23,882 |
Cantley Lewis Clayton Jr. | Director | 05/25/2017 | 23,882 |
Cantley Lewis Clayton Jr. | Director | 05/24/2017 | 24,060 |
Cantley Lewis Clayton Jr. | Director | 05/24/2017 | 24,060 |
Schenkein David P | Chief Executive Officer | 05/01/2017 | 908 |
Schenkein David P | Chief Executive Officer | 05/01/2017 | 150,180 |
Celgene European Investment Co LLC | 10% Owner | 04/24/2017 | 30,916,463 |
Cantley Lewis Clayton Jr. | Director | 04/18/2017 | 25,918 |
Cantley Lewis Clayton Jr. | Director | 04/18/2017 | 25,918 |
Cantley Lewis Clayton Jr. | Director | 04/17/2017 | 112,458 |
Cantley Lewis Clayton Jr. | Director | 04/17/2017 | 112,458 |
Biller Scott | Chief Scientific Officer | 04/03/2017 | 19,421 |
Biller Scott | Chief Scientific Officer | 04/03/2017 | 124,532 |
Schenkein David P | Chief Executive Officer | 04/03/2017 | 908 |
Schenkein David P | Chief Executive Officer | 04/03/2017 | 175,860 |
Cantley Lewis Clayton Jr. | Director | 03/23/2017 | 27,440 |
Cantley Lewis Clayton Jr. | Director | 03/23/2017 | 27,440 |
Cantley Lewis Clayton Jr. | Director | 03/22/2017 | 26,626 |
Cantley Lewis Clayton Jr. | Director | 03/22/2017 | 26,626 |
Biller Scott | Chief Scientific Officer | 03/20/2017 | 53,930 |
Biller Scott | Chief Scientific Officer | 03/20/2017 | 354,090 |
NELSEN ROBERT | Director | 03/06/2017 | 1,977 |
NELSEN ROBERT | Director | 03/03/2017 | 2,062,232 |
NELSEN ROBERT | Director | 02/28/2017 | 2,381,815 |
NELSEN ROBERT | Director | 02/27/2017 | 9,616,080 |
NELSEN ROBERT | Director | 02/22/2017 | 2,392,754 |
NELSEN ROBERT | Director | 02/21/2017 | 1,848,249 |
NELSEN ROBERT | Director | 02/23/2017 | 2,442,461 |
Schenkein David P | Chief Executive Officer | 02/16/2017 | 1,815 |
Schenkein David P | Chief Executive Officer | 02/16/2017 | 300,060 |
Biller Scott | Chief Scientific Officer | 11/14/2016 | 337,037 |
Biller Scott | Chief Scientific Officer | 11/14/2016 | 325,000 |
Biller Scott | Chief Scientific Officer | 11/14/2016 | 1,787,500 |
Biller Scott | Chief Scientific Officer | 11/10/2016 | 127,680 |
Biller Scott | Chief Scientific Officer | 11/09/2016 | 172,320 |
Cantley Lewis Clayton Jr. | Director | 10/27/2016 | 30,606 |
Cantley Lewis Clayton Jr. | Director | 10/27/2016 | 30,704 |
Cantley Lewis Clayton Jr. | Director | 10/26/2016 | 30,569 |
Cantley Lewis Clayton Jr. | Director | 10/26/2016 | 30,667 |
Biller Scott | Chief Scientific Officer | 10/05/2016 | 275,000 |
Cantley Lewis Clayton Jr. | Director | 09/28/2016 | 33,750 |
Cantley Lewis Clayton Jr. | Director | 09/28/2016 | 33,858 |
Cantley Lewis Clayton Jr. | Director | 09/27/2016 | 33,844 |
Cantley Lewis Clayton Jr. | Director | 09/27/2016 | 33,952 |
Biller Scott | Chief Scientific Officer | 09/20/2016 | 250,000 |
Cantley Lewis Clayton Jr. | Director | 08/30/2016 | 23,006 |
Cantley Lewis Clayton Jr. | Director | 08/30/2016 | 23,080 |
Cantley Lewis Clayton Jr. | Director | 08/29/2016 | 23,631 |
Cantley Lewis Clayton Jr. | Director | 08/29/2016 | 23,707 |
Cantley Lewis Clayton Jr. | Director | 07/25/2016 | 26,156 |
Cantley Lewis Clayton Jr. | Director | 07/25/2016 | 26,240 |
Cantley Lewis Clayton Jr. | Director | 07/26/2016 | 27,338 |
Cantley Lewis Clayton Jr. | Director | 07/26/2016 | 27,425 |
Cantley Lewis Clayton Jr. | Director | 06/28/2016 | 27,113 |
Cantley Lewis Clayton Jr. | Director | 06/28/2016 | 27,199 |
Cantley Lewis Clayton Jr. | Director | 06/27/2016 | 25,231 |
Cantley Lewis Clayton Jr. | Director | 06/27/2016 | 25,312 |
Biller Scott | Chief Scientific Officer | 06/08/2016 | 174,766 |
Biller Scott | Chief Scientific Officer | 06/10/2016 | 7,106 |
Biller Scott | Chief Scientific Officer | 06/08/2016 | 1,787,500 |
Cantley Lewis Clayton Jr. | Director | 05/26/2016 | 33,050 |
Cantley Lewis Clayton Jr. | Director | 05/26/2016 | 33,156 |
Cantley Lewis Clayton Jr. | Director | 05/25/2016 | 31,563 |
Cantley Lewis Clayton Jr. | Director | 05/25/2016 | 31,664 |
Cantley Lewis Clayton Jr. | Director | 04/26/2016 | 32,425 |
Cantley Lewis Clayton Jr. | Director | 04/26/2016 | 32,529 |
Cantley Lewis Clayton Jr. | Director | 04/25/2016 | 34,375 |
Cantley Lewis Clayton Jr. | Director | 04/25/2016 | 34,485 |
Cantley Lewis Clayton Jr. | Director | 03/29/2016 | 22,748 |
Cantley Lewis Clayton Jr. | Director | 03/30/2016 | 23,806 |
Cantley Lewis Clayton Jr. | Director | 03/30/2016 | 23,882 |
Cantley Lewis Clayton Jr. | Director | 03/29/2016 | 22,675 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,450 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,365 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 81,029 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 81,162 |
Cantley Lewis Clayton Jr. | Director | 02/25/2016 | 23,063 |
Cantley Lewis Clayton Jr. | Director | 02/25/2016 | 23,136 |
Cantley Lewis Clayton Jr. | Director | 02/26/2016 | 24,306 |
Cantley Lewis Clayton Jr. | Director | 02/26/2016 | 24,384 |
Biller Scott | Chief Scientific Officer | 02/03/2016 | 4,675 |
Cantley Lewis Clayton Jr. | Director | 01/28/2016 | 27,795 |
Cantley Lewis Clayton Jr. | Director | 01/29/2016 | 25,950 |
Cantley Lewis Clayton Jr. | Director | 01/29/2016 | 26,033 |
Cantley Lewis Clayton Jr. | Director | 01/28/2016 | 27,706 |
Biller Scott | Chief Scientific Officer | 01/07/2016 | 7,013 |
Schenkein David P | Chief Executive Officer | 01/07/2016 | 6,050 |
Biller Scott | Chief Scientific Officer | 12/31/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 12/31/2015 | 358,985 |
Higgons John Duncan | Chief Operating Officer | 01/04/2016 | 195,925 |
Schenkein David P | Chief Executive Officer | 01/04/2016 | 3,025 |
Schenkein David P | Chief Executive Officer | 01/05/2016 | 3,025 |
Cantley Lewis Clayton Jr. | Director | 12/29/2015 | 176,647 |
Cantley Lewis Clayton Jr. | Director | 12/28/2015 | 169,623 |
Cantley Lewis Clayton Jr. | Director | 12/28/2015 | 169,649 |
Cantley Lewis Clayton Jr. | Director | 12/29/2015 | 176,514 |
Higgons John Duncan | Chief Operating Officer | 12/15/2015 | 1,001,800 |
Biller Scott | Chief Scientific Officer | 11/30/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 11/30/2015 | 362,945 |
Higgons John Duncan | Chief Operating Officer | 11/16/2015 | 21,764 |
Higgons John Duncan | Chief Operating Officer | 11/16/2015 | 1,230,200 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,450 |
Cantley Lewis Clayton Jr. | Director | 11/17/2015 | 209,365 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 72,028 |
Cantley Lewis Clayton Jr. | Director | 11/16/2015 | 72,028 |
Biller Scott | Chief Scientific Officer | 11/02/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 11/02/2015 | 424,160 |
Schenkein David P | Chief Executive Officer | 10/27/2015 | 126,560 |
Schenkein David P | Chief Executive Officer | 10/27/2015 | 321,040 |
Cantley Lewis Clayton Jr. | Director | 10/22/2015 | 148,495 |
Cantley Lewis Clayton Jr. | Director | 10/23/2015 | 148,229 |
Cantley Lewis Clayton Jr. | Director | 10/23/2015 | 148,253 |
Cantley Lewis Clayton Jr. | Director | 10/22/2015 | 148,520 |
Higgons John Duncan | Chief Operating Officer | 10/15/2015 | 6,244 |
Higgons John Duncan | Chief Operating Officer | 10/15/2015 | 1,420,800 |
Higgons John Duncan | Chief Operating Officer | 09/30/2015 | 3,025 |
Biller Scott | Chief Scientific Officer | 09/30/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 09/30/2015 | 387,420 |
Goddard Glenn | Senior Vice President, Finance | 09/24/2015 | 431,650 |
Goddard Glenn | Senior Vice President, Finance | 09/24/2015 | 19,774 |
Goddard Glenn | Senior Vice President, Finance | 09/24/2015 | 515,820 |
Cantley Lewis Clayton Jr. | Director | 09/24/2015 | 204,827 |
Cantley Lewis Clayton Jr. | Director | 09/25/2015 | 199,102 |
Cantley Lewis Clayton Jr. | Director | 09/25/2015 | 199,150 |
Cantley Lewis Clayton Jr. | Director | 09/24/2015 | 204,803 |
Higgons John Duncan | Chief Operating Officer | 09/15/2015 | 6,050 |
Higgons John Duncan | Chief Operating Officer | 09/15/2015 | 1,822,200 |
Higgons John Duncan | Chief Operating Officer | 08/20/2015 | 3,025 |
Higgons John Duncan | Chief Operating Officer | 08/17/2015 | 6,050 |
Higgons John Duncan | Chief Operating Officer | 08/17/2015 | 1,844,800 |
Cantley Lewis Clayton Jr. | Director | 08/18/2015 | 232,144 |
Cantley Lewis Clayton Jr. | Director | 08/18/2015 | 232,144 |
Cantley Lewis Clayton Jr. | Director | 08/17/2015 | 228,481 |
Cantley Lewis Clayton Jr. | Director | 08/17/2015 | 228,553 |
Biller Scott | Chief Scientific Officer | 08/10/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 08/10/2015 | 550,000 |
Higgons John Duncan | Chief Operating Officer | 08/06/2015 | 3,025 |
Schenkein David P | Chief Executive Officer | 08/03/2015 | 231,152 |
Schenkein David P | Chief Executive Officer | 08/03/2015 | 884,800 |
Goddard Glenn | Senior Vice President, Finance | 07/23/2015 | 210,216 |
Goddard Glenn | Senior Vice President, Finance | 07/23/2015 | 843,150 |
Biller Scott | Chief Scientific Officer | 07/20/2015 | 174,020 |
Biller Scott | Chief Scientific Officer | 07/20/2015 | 626,285 |
Goddard Glenn | Senior Vice President, Finance | 07/17/2015 | 76,603 |
Goddard Glenn | Senior Vice President, Finance | 07/17/2015 | 1,478,230 |
Cantley Lewis Clayton Jr. | Director | 07/16/2015 | 276,976 |
Cantley Lewis Clayton Jr. | Director | 07/15/2015 | 277,413 |
Cantley Lewis Clayton Jr. | Director | 07/15/2015 | 277,486 |
Cantley Lewis Clayton Jr. | Director | 07/16/2015 | 277,049 |
Higgons John Duncan | Chief Operating Officer | 07/16/2015 | 6,050 |
Higgons John Duncan | Chief Operating Officer | 07/16/2015 | 2,280,400 |
Biller Scott | Chief Scientific Officer | 05/07/2015 | 529,760 |
Biller Scott | Chief Scientific Officer | 04/08/2015 | 537,020 |
Biller Scott | Chief Scientific Officer | 06/26/2015 | 3,506 |
Cantley Lewis Clayton Jr. | Director | 06/24/2015 | 253,760 |
Cantley Lewis Clayton Jr. | Director | 06/25/2015 | 256,331 |
Cantley Lewis Clayton Jr. | Director | 06/25/2015 | 256,331 |
Cantley Lewis Clayton Jr. | Director | 06/24/2015 | 253,735 |
Biller Scott | Chief Scientific Officer | 06/16/2015 | 140 |
Higgons John Duncan | Chief Operating Officer | 06/15/2015 | 736,610 |
Higgons John Duncan | Chief Operating Officer | 06/12/2015 | 3,025 |
Higgons John Duncan | Chief Operating Officer | 06/11/2015 | 3,025 |
Higgons John Duncan | Chief Operating Officer | 06/10/2015 | 3,025 |
Biller Scott | Chief Scientific Officer | 06/08/2015 | 670,175 |
Schenkein David P | Chief Executive Officer | 06/01/2015 | 1,568,710 |
Bowden Christopher | Chief Medical Officer | 06/01/2015 | 175,800 |
Bowden Christopher | Chief Medical Officer | 06/01/2015 | 603,350 |
Schenkein David P | Chief Executive Officer | 05/27/2015 | 1,071,926 |
Goddard Glenn | Senior Vice President, Finance | 05/27/2015 | 50,150 |
Goddard Glenn | Senior Vice President, Finance | 05/27/2015 | 260,629 |
Cantley Lewis Clayton Jr. | Director | 05/19/2015 | 283,017 |
Cantley Lewis Clayton Jr. | Director | 05/19/2015 | 283,090 |
Cantley Lewis Clayton Jr. | Director | 05/20/2015 | 282,872 |
Cantley Lewis Clayton Jr. | Director | 05/20/2015 | 282,872 |
Higgons John Duncan | Chief Operating Officer | 05/15/2015 | 837,305 |
Schenkein David P | Chief Executive Officer | 05/12/2015 | 230,293 |
Schenkein David P | Chief Executive Officer | 05/11/2015 | 341,801 |
Schenkein David P | Chief Executive Officer | 05/07/2015 | 3,025 |
Schenkein David P | Chief Executive Officer | 05/08/2015 | 395,148 |
Schenkein David P | Chief Executive Officer | 05/01/2015 | 365,157 |
Cantley Lewis Clayton Jr. | Director | 04/24/2015 | 258,345 |
Cantley Lewis Clayton Jr. | Director | 04/24/2015 | 258,248 |
Cantley Lewis Clayton Jr. | Director | 04/23/2015 | 251,892 |
Cantley Lewis Clayton Jr. | Director | 04/23/2015 | 251,867 |
Higgons John Duncan | Chief Operating Officer | 04/15/2015 | 655,272 |
Schenkein David P | Chief Executive Officer | 04/13/2015 | 390,117 |
Schenkein David P | Chief Executive Officer | 04/01/2015 | 360,906 |
Cantley Lewis Clayton Jr. | Director | 03/27/2015 | 233,697 |
Cantley Lewis Clayton Jr. | Director | 03/27/2015 | 233,745 |
Cantley Lewis Clayton Jr. | Director | 03/26/2015 | 220,305 |
Cantley Lewis Clayton Jr. | Director | 03/26/2015 | 220,378 |
Higgons John Duncan | Chief Operating Officer | 03/16/2015 | 743,680 |
Goddard Glenn | Senior Vice President, Finance | 03/16/2015 | 272,624 |
Goddard Glenn | Senior Vice President, Finance | 03/16/2015 | 1,062,400 |
Biller Scott | Chief Scientific Officer | 03/16/2015 | 2,571 |
Biller Scott | Chief Scientific Officer | 03/16/2015 | 587,455 |
Schenkein David P | Chief Executive Officer | 03/05/2015 | 286,416 |
Biller Scott | Chief Scientific Officer | 02/27/2015 | 10,624 |
Schenkein David P | Chief Executive Officer | 02/27/2015 | 7,563 |
Schenkein David P | Chief Executive Officer | 03/02/2015 | 834,990 |
Goddard Glenn | Senior Vice President, Finance | 02/13/2015 | 30,400 |
Goddard Glenn | Senior Vice President, Finance | 02/13/2015 | 158,328 |
Schenkein David P | Chief Executive Officer | 02/13/2015 | 82,292 |
Schenkein David P | Chief Executive Officer | 02/11/2015 | 94,550 |
Goddard Glenn | Senior Vice President, Finance | 02/09/2015 | 331,237 |
Goddard Glenn | Senior Vice President, Finance | 02/11/2015 | 34,950 |
Goddard Glenn | Senior Vice President, Finance | 02/11/2015 | 181,772 |
Goddard Glenn | Senior Vice President, Finance | 02/09/2015 | 1,587,150 |
Schenkein David P | Chief Executive Officer | 02/02/2015 | 1,188,824 |
Biller Scott | Chief Scientific Officer | 01/02/2015 | 2,104 |
Biller Scott | Chief Scientific Officer | 01/02/2015 | 495,360 |
Schenkein David P | Chief Executive Officer | 01/02/2015 | 1,431,040 |
Higgons John Duncan | Chief Operating Officer | 01/02/2015 | 1,320,960 |
Higgons John Duncan | Chief Operating Officer | 01/02/2015 | 1,320,960 |
MARAGANORE JOHN | Director | 12/16/2014 | 200,015 |
Celgene European Investment Co LLC | 10% Owner | 12/16/2014 | 25,322,434 |
Schenkein David P | Chief Executive Officer | 12/01/2014 | 1,261,390 |
Higgons John Duncan | Chief Operating Officer | 12/01/2014 | 1,164,360 |
Biller Scott | Chief Scientific Officer | 12/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 12/01/2014 | 436,635 |
Biller Scott | Chief Scientific Officer | 11/20/2014 | 3,506 |
Schenkein David P | Chief Executive Officer | 11/03/2014 | 1,062,230 |
Goddard Glenn | Senior Vice President, Finance | 11/03/2014 | 16,193 |
Goddard Glenn | Senior Vice President, Finance | 11/03/2014 | 163,420 |
Higgons John Duncan | Chief Operating Officer | 11/03/2014 | 1,062,230 |
Biller Scott | Chief Scientific Officer | 11/03/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 11/03/2014 | 367,695 |
Schenkein David P | Chief Executive Officer | 10/01/2014 | 756 |
Schenkein David P | Chief Executive Officer | 10/01/2014 | 780,910 |
Higgons John Duncan | Chief Operating Officer | 10/01/2014 | 780,910 |
Biller Scott | Chief Scientific Officer | 10/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 10/01/2014 | 270,315 |
Goddard Glenn | Senior Vice President, Finance | 10/01/2014 | 13,575 |
Goddard Glenn | Senior Vice President, Finance | 10/01/2014 | 90,105 |
Goddard Glenn | Senior Vice President, Finance | 09/26/2014 | 91,222 |
Goddard Glenn | Senior Vice President, Finance | 09/26/2014 | 989,275 |
Schenkein David P | Chief Executive Officer | 09/26/2014 | 9,075 |
Schenkein David P | Chief Executive Officer | 09/26/2014 | 3,760,800 |
Biller Scott | Chief Scientific Officer | 09/19/2014 | 17,763 |
Biller Scott | Chief Scientific Officer | 09/19/2014 | 1,916,898 |
Biller Scott | Chief Scientific Officer | 09/02/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 08/07/2014 | 2,338 |
Biller Scott | Chief Scientific Officer | 09/02/2014 | 208,350 |
Goddard Glenn | Senior Vice President, Finance | 09/02/2014 | 22,648 |
Goddard Glenn | Senior Vice President, Finance | 09/02/2014 | 463,000 |
Schenkein David P | Chief Executive Officer | 09/02/2014 | 1,966 |
Schenkein David P | Chief Executive Officer | 09/02/2014 | 601,900 |
Higgons John Duncan | Chief Operating Officer | 09/02/2014 | 2,040 |
Higgons John Duncan | Chief Operating Officer | 09/02/2014 | 601,900 |
Higgons John Duncan | Chief Operating Officer | 08/26/2014 | 1,513 |
Higgons John Duncan | Chief Operating Officer | 08/26/2014 | 225,250 |
Schenkein David P | Chief Executive Officer | 08/11/2014 | 181,970 |
Schenkein David P | Chief Executive Officer | 08/01/2014 | 331,770 |
Higgons John Duncan | Chief Operating Officer | 08/01/2014 | 2,118 |
Higgons John Duncan | Chief Operating Officer | 08/01/2014 | 273,630 |
Biller Scott | Chief Scientific Officer | 08/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 08/01/2014 | 175,905 |
Schenkein David P | Chief Executive Officer | 07/01/2014 | 604,760 |
Goddard Glenn | Senior Vice President, Finance | 07/01/2014 | 3,893 |
Goddard Glenn | Senior Vice President, Finance | 07/01/2014 | 162,820 |
Higgons John Duncan | Chief Operating Officer | 07/01/2014 | 558,240 |
Biller Scott | Chief Scientific Officer | 07/01/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 07/01/2014 | 209,340 |
MARAGANORE JOHN | Director | 06/23/2014 | 101,154 |
Biller Scott | Chief Scientific Officer | 06/20/2014 | 937 |
Biller Scott | Chief Scientific Officer | 06/20/2014 | 100,300 |
Higgons John Duncan | Chief Operating Officer | 06/13/2014 | 226,350 |
Higgons John Duncan | Chief Operating Officer | 06/03/2014 | 129,537 |
Higgons John Duncan | Chief Operating Officer | 06/02/2014 | 111,771 |
Biller Scott | Chief Scientific Officer | 06/02/2014 | 2,104 |
Biller Scott | Chief Scientific Officer | 06/02/2014 | 151,920 |
Higgons John Duncan | Chief Operating Officer | 05/06/2014 | 228,650 |
Goddard Glenn | Senior Vice President, Finance | 05/01/2014 | 2,532 |
Goddard Glenn | Senior Vice President, Finance | 05/01/2014 | 84,780 |
Higgons John Duncan | Chief Operating Officer | 05/01/2014 | 908 |
Higgons John Duncan | Chief Operating Officer | 05/01/2014 | 296,730 |
Biller Scott | Chief Scientific Officer | 05/01/2014 | 6,311 |
Biller Scott | Chief Scientific Officer | 05/01/2014 | 572,265 |
MARAGANORE JOHN | Director | 04/29/2014 | 99,000 |
Celgene European Investment Co LLC | 10% Owner | 04/29/2014 | 12,971,200 |
Higgons John Duncan | Chief Operating Officer | 04/07/2014 | 908 |
Higgons John Duncan | Chief Operating Officer | 04/07/2014 | 135,510 |
Goddard Glenn | Senior Vice President, Finance | 04/07/2014 | 2,315 |
Goddard Glenn | Senior Vice President, Finance | 04/07/2014 | 90,340 |
Goddard Glenn | Senior Vice President, Finance | 04/01/2014 | 2,542 |
Goddard Glenn | Senior Vice President, Finance | 04/01/2014 | 152,320 |
Higgons John Duncan | Chief Operating Officer | 04/01/2014 | 3,630 |
Higgons John Duncan | Chief Operating Officer | 04/01/2014 | 456,960 |
Biller Scott | Chief Scientific Officer | 04/01/2014 | 16,129 |
Biller Scott | Chief Scientific Officer | 04/01/2014 | 171,360 |
Tessier-Lavigne Marc | Director | 07/24/2013 | 999,990 |
MARAGANORE JOHN | Director | 07/24/2013 | 149,994 |
Schenkein David P | Chief Executive Officer | 03/25/2014 | 7,563 |
Higgons John Duncan | Chief Operating Officer | 03/19/2014 | 24,200 |
Schenkein David P | Chief Executive Officer | 03/10/2014 | 16,335 |
Higgons John Duncan | Chief Operating Officer | 03/10/2014 | 6,050 |
Goddard Glenn | Senior Vice President, Finance | 03/07/2014 | 6,123 |
Goddard Glenn | Senior Vice President, Finance | 03/06/2014 | 2,556 |
Goddard Glenn | Senior Vice President, Finance | 03/07/2014 | 541,200 |
Goddard Glenn | Senior Vice President, Finance | 03/06/2014 | 194,333 |
Higgons John Duncan | Chief Operating Officer | 03/07/2014 | 2,723 |
Higgons John Duncan | Chief Operating Officer | 03/06/2014 | 1,708 |
Higgons John Duncan | Chief Operating Officer | 03/06/2014 | 200,659 |
Higgons John Duncan | Chief Operating Officer | 03/07/2014 | 405,900 |
Higgons John Duncan | Chief Operating Officer | 03/03/2014 | 2,420 |
Higgons John Duncan | Chief Operating Officer | 03/03/2014 | 238,832 |
Biller Scott | Chief Scientific Officer | 03/03/2014 | 2,805 |
Biller Scott | Chief Scientific Officer | 03/03/2014 | 179,124 |
Goddard Glenn | Senior Vice President, Finance | 02/18/2014 | 1,651 |
Goddard Glenn | Senior Vice President, Finance | 02/18/2014 | 123,832 |
Higgons John Duncan | Chief Operating Officer | 02/18/2014 | 712 |
Higgons John Duncan | Chief Operating Officer | 02/18/2014 | 82,531 |
Goddard Glenn | Senior Vice President, Finance | 02/10/2014 | 2,805 |
Goddard Glenn | Senior Vice President, Finance | 02/10/2014 | 182,640 |
Higgons John Duncan | Chief Operating Officer | 02/03/2014 | 2,420 |
Higgons John Duncan | Chief Operating Officer | 02/03/2014 | 207,728 |
Biller Scott | Chief Scientific Officer | 02/03/2014 | 2,805 |
Biller Scott | Chief Scientific Officer | 02/03/2014 | 155,796 |
Goddard Glenn | Senior Vice President, Finance | 01/27/2014 | 3,273 |
Goddard Glenn | Senior Vice President, Finance | 01/27/2014 | 184,051 |
Biller Scott | Chief Scientific Officer | 01/21/2014 | 2,805 |
Biller Scott | Chief Scientific Officer | 01/21/2014 | 208,265 |
Higgons John Duncan | Chief Operating Officer | 01/21/2014 | 3,630 |
Higgons John Duncan | Chief Operating Officer | 01/21/2014 | 416,530 |
Goddard Glenn | Senior Vice President, Finance | 01/21/2014 | 4,675 |
Goddard Glenn | Senior Vice President, Finance | 01/21/2014 | 347,108 |
Celgene European Investment Co LLC | 10% Owner | 07/29/2013 | 12,749,994 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AGIOS PHARMACEUTICALS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 4,962,237 | 0.00282% | 6.69% | Other |
FARALLON CAPITAL MANAGEMENT LLC | 4,167,602 | 0.46% | 51.5% | Event Driven, Value |
GEODE CAPITAL MANAGEMENT, LLC | 1,254,277 | 0.00292% | 4.61% | Other |
FISHER ASSET MANAGEMENT, LLC | 711,521 | 0.00838% | -12.96% | Other |
SUVRETTA CAPITAL MANAGEMENT, LLC | 399,451 | 0.4% | -12.02% | Growth At A Reasonable Price |
D. E. SHAW & CO., INC. | 216,484 | 0.00421% | 36.77% | Other |
UBS OCONNOR LLC | 126,819 | 0.2% | 20.53% | Value |
ORBIMED ADVISORS LLC | 45,000 | 0.02% | New | Other |
RENAISSANCE TECHNOLOGIES LLC | 42,714 | 0.00147% | New | Other |
BALYASNY ASSET MANAGEMENT L.P. | 42,003 | 0.00176% | -84.15% | Event Driven |
ALPS ADVISORS INC | 37,844 | 0.00663% | -7.92% | Other |
TUDOR INVESTMENT CORP ET AL | 27,898 | 0.005% | New | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR AGIOS PHARMACEUTICALS INC
STOCK BUYBACKS FOR AGIOS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.22%
1Q
06/30/2023
0.58%
2Q
03/31/2023
1.20%
3Q
12/31/2022
1.77%
4Q
09/30/2022
1.97%
5Q
06/30/2022
2.06%
6Q
03/31/2022
2.51%
7Q
12/31/2021
3.03%
8Q
09/30/2021
-1.97%
9Q
06/30/2021
-8.42%
10Q
03/31/2021
-19.58%
11Q
12/31/2020
-19.27%
12Q
09/30/2020
-19.12%
13Q
06/30/2020
-18.90%
14Q
03/31/2020
-18.48%
15Q
12/31/2019
-12.61%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AGIOS PHARMACEUTICALS INC
LOADING...